This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-141-3p | ABL1 | 0.73 | 0.00012 | 0.08 | 0.3604 | MirTarget | -0.2 | 0 | NA | |
2 | hsa-miR-149-5p | ABL1 | 0.44 | 0.0642 | 0.08 | 0.3604 | miRNAWalker2 validate | -0.12 | 0 | NA | |
3 | hsa-miR-19a-3p | ABL1 | 1.36 | 0 | 0.08 | 0.3604 | mirMAP | -0.17 | 0 | NA | |
4 | hsa-miR-200a-3p | ABL1 | 0.61 | 0.0029 | 0.08 | 0.3604 | MirTarget | -0.17 | 0 | NA | |
5 | hsa-miR-203a-3p | ABL1 | 0.04 | 0.88046 | 0.08 | 0.3604 | miRTarBase | -0.11 | 0 | 21454413 | Treatment of lymphoma B cells with demethylating agents led to increased miR-203 expression and the concomitant downregulation of ABL1 confirming the epigenetic regulation of this miRNA; In summary our results show that the transformation from gastritis to MALT lymphoma is epigenetically regulated by miR-203 promoter methylation and identify ABL1 as a novel target for the treatment of this malignancy |
6 | hsa-miR-29a-5p | ABL1 | 0.32 | 0.03704 | 0.08 | 0.3604 | MirTarget | -0.1 | 7.0E-5 | NA | |
7 | hsa-miR-29b-3p | ABL1 | -0.11 | 0.51126 | 0.08 | 0.3604 | miRNATAP | -0.15 | 0 | NA | |
8 | hsa-miR-30b-5p | ABL1 | -0.4 | 0.00347 | 0.08 | 0.3604 | MirTarget; miRNATAP | -0.17 | 0 | NA | |
9 | hsa-miR-30c-5p | ABL1 | 0.02 | 0.88637 | 0.08 | 0.3604 | MirTarget; miRNATAP | -0.19 | 0 | NA | |
10 | hsa-miR-193a-3p | ANAPC1 | 0.22 | 0.11183 | 0.11 | 0.29388 | miRanda | -0.12 | 0.00016 | NA | |
11 | hsa-miR-26b-5p | ANAPC1 | -0.25 | 0.02852 | 0.11 | 0.29388 | miRNAWalker2 validate | -0.19 | 0 | NA | |
12 | hsa-miR-100-5p | ANAPC11 | -1.86 | 0 | 0.23 | 0.03985 | miRNAWalker2 validate | -0.1 | 5.0E-5 | NA | |
13 | hsa-miR-542-3p | ANAPC7 | 0.64 | 0 | -0.08 | 0.21953 | miRanda | -0.1 | 0 | NA | |
14 | hsa-miR-18a-5p | ATM | 1.65 | 0 | -0.09 | 0.45414 | miRNAWalker2 validate; miRTarBase; MirTarget | -0.17 | 0 | 23437304; 25963391; 23857602; 23229340 | MicroRNA 18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer; Through in silico search the 3'UTR of Ataxia telangiectasia mutated ATM contains a conserved miR-18a binding site; Expression of ATM was down-regulated in CRC tumors p<0.0001 and inversely correlated with miR-18a expression r = -0.4562 p<0.01; This was further confirmed by the down-regulation of ATM protein by miR-18a; As ATM is a key enzyme in DNA damage repair we evaluated the effect of miR-18a on DNA double-strand breaks; miR-18a attenuates cellular repair of DNA double-strand breaks by directly suppressing ATM a key enzyme in DNA damage repair;However the upregulation of miR-18a suppressed the level of ataxia-telangiectasia mutated and attenuated DNA double-strand break repair after irradiation which re-sensitized the cervical cancer cells to radiotherapy by promoting apoptosis;Furthermore we used antisense oligonucleotides against micro RNAs miRNA or miRNA overexpression plasmids to study the role of miR-18a and -106a on ATM expression; Furthermore we identified that ERα activates miR-18a and -106a to downregulate ATM expression; We reveal a novel mechanism involving ERα and miR-18a and -106a regulation of ATM in breast cancer;MicroRNA 18a upregulates autophagy and ataxia telangiectasia mutated gene expression in HCT116 colon cancer cells; Previous studies showed that certain microRNAs including miR-18a potentially regulate ATM in cancer cells; However the mechanisms behind the modulation of ATM by miR-18a remain to be elucidated in colon cancer cells; In the present study we explored the impact of miR-18a on the autophagy process and ATM expression in HCT116 colon cancer cells; Western blotting and luciferase assays were implemented to explore the impact of miR-18a on ATM gene expression in HCT116 cells; Moreover miR-18a overexpression led to the upregulation of ATM expression and suppression of mTORC1 activity; Results of the present study pertaining to the role of miR-18a in regulating autophagy and ATM gene expression in colon cancer cells revealed a novel function for miR-18a in a critical cellular event and on a crucial gene with significant impacts in cancer development progression treatment and in other diseases |
15 | hsa-miR-19b-3p | ATM | 0.54 | 0.00062 | -0.09 | 0.45414 | miRNAWalker2 validate | -0.19 | 0 | NA | |
16 | hsa-miR-203a-3p | ATM | 0.04 | 0.88046 | -0.09 | 0.45414 | MirTarget | -0.1 | 0 | 24145123; 27542403 | miR 203 induces oxaliplatin resistance in colorectal cancer cells by negatively regulating ATM kinase; In silico analysis identified ataxia telangiectasia mutated ATM a primary mediator of the DNA damage response as a potential target of miR-203; Using TCGA database we identified a significant reverse correlation of miR-203 and ATM expression in CRC tissues; We validated ATM as a bona fide target of miR-203 in CRC cells; Mutation of the putative miR-203 binding site in the 3' untranslated region 3'UTR of the ATM mRNA abolished the inhibitory effect of miR-203 on ATM;MiR 203 inhibits tumor invasion and metastasis in gastric cancer by ATM; Our results showed that miR-203 was significantly downregulated in gastric cancer tissues and cells while ataxia telangiectasia mutated kinase ATM was upregulated in gastric cancer tissues and cells and was directly regulated by miR-203; ATM knockdown phenocopied the effect of miR-203 overexpression |
17 | hsa-miR-21-5p | ATM | 1.62 | 0 | -0.09 | 0.45414 | mirMAP | -0.14 | 0.00355 | 26289851 | MiR-21 is an oncomiR that is overexpressed in nearly all cancers including ATC; Hence suppression of miR-21 could pave the way for ATC therapy |
18 | hsa-miR-30c-5p | ATM | 0.02 | 0.88637 | -0.09 | 0.45414 | mirMAP | -0.12 | 0.00081 | NA | |
19 | hsa-miR-339-5p | ATM | 1.08 | 0 | -0.09 | 0.45414 | miRanda | -0.14 | 0 | NA | |
20 | hsa-miR-455-5p | ATM | 1.41 | 0 | -0.09 | 0.45414 | miRanda | -0.22 | 0 | NA | |
21 | hsa-miR-500a-5p | ATM | 0.68 | 8.0E-5 | -0.09 | 0.45414 | mirMAP | -0.14 | 1.0E-5 | NA | |
22 | hsa-miR-576-5p | ATM | 0.94 | 0 | -0.09 | 0.45414 | mirMAP | -0.17 | 2.0E-5 | NA | |
23 | hsa-miR-590-5p | ATM | 0.76 | 0 | -0.09 | 0.45414 | mirMAP | -0.15 | 0.00038 | NA | |
24 | hsa-miR-30b-5p | ATR | -0.4 | 0.00347 | 0.34 | 0.00089 | mirMAP | -0.11 | 0.00089 | NA | |
25 | hsa-miR-139-5p | BUB1 | -1.46 | 0 | 1.79 | 0 | miRanda | -0.29 | 0 | NA | |
26 | hsa-miR-199a-5p | BUB1 | -0.36 | 0.04351 | 1.79 | 0 | miRanda | -0.19 | 0 | NA | |
27 | hsa-miR-199b-5p | BUB1 | -1.08 | 0 | 1.79 | 0 | miRanda | -0.23 | 0 | NA | |
28 | hsa-miR-495-3p | BUB1 | -1.48 | 0 | 1.79 | 0 | MirTarget | -0.2 | 0 | NA | |
29 | hsa-miR-653-5p | BUB1 | -1.05 | 0 | 1.79 | 0 | MirTarget | -0.2 | 0 | NA | |
30 | hsa-miR-22-3p | BUB1B | 0.01 | 0.92636 | 1.71 | 0 | miRNAWalker2 validate | -0.28 | 0.0008 | NA | |
31 | hsa-miR-486-5p | BUB1B | -1.7 | 0 | 1.71 | 0 | miRanda | -0.11 | 0.00012 | NA | |
32 | hsa-miR-107 | CCNA1 | -0.04 | 0.67162 | 1.54 | 0.00197 | miRanda | -0.68 | 0.00113 | NA | |
33 | hsa-miR-30a-5p | CCNA1 | -1.8 | 0 | 1.54 | 0.00197 | MirTarget | -0.48 | 9.0E-5 | NA | |
34 | hsa-miR-30b-5p | CCNA1 | -0.4 | 0.00347 | 1.54 | 0.00197 | MirTarget | -0.5 | 0.00164 | NA | |
35 | hsa-miR-30c-5p | CCNA1 | 0.02 | 0.88637 | 1.54 | 0.00197 | MirTarget | -0.44 | 0.00251 | NA | |
36 | hsa-miR-30d-5p | CCNA1 | -0.38 | 0.00017 | 1.54 | 0.00197 | MirTarget | -1.15 | 0 | NA | |
37 | hsa-miR-30e-5p | CCNA1 | -1.02 | 0 | 1.54 | 0.00197 | MirTarget | -1.32 | 0 | NA | |
38 | hsa-miR-320b | CCNA1 | 1.23 | 0 | 1.54 | 0.00197 | miRanda | -0.45 | 0.00063 | NA | |
39 | hsa-miR-199a-5p | CCNA2 | -0.36 | 0.04351 | 1.57 | 0 | miRanda | -0.21 | 0 | NA | |
40 | hsa-miR-199b-5p | CCNA2 | -1.08 | 0 | 1.57 | 0 | miRanda | -0.23 | 0 | NA | |
41 | hsa-miR-218-5p | CCNA2 | -1.07 | 0 | 1.57 | 0 | MirTarget | -0.14 | 6.0E-5 | NA | |
42 | hsa-miR-299-5p | CCNA2 | -1.92 | 0 | 1.57 | 0 | miRNATAP | -0.24 | 0 | NA | |
43 | hsa-miR-29a-3p | CCNA2 | -1.27 | 0 | 1.57 | 0 | MirTarget | -0.12 | 0.00994 | NA | |
44 | hsa-miR-29c-3p | CCNA2 | -2.08 | 0 | 1.57 | 0 | MirTarget | -0.12 | 0.00012 | NA | |
45 | hsa-miR-139-5p | CCNB1 | -1.46 | 0 | 1.45 | 0 | miRanda | -0.2 | 0 | NA | |
46 | hsa-let-7a-5p | CCNB2 | -0.44 | 3.0E-5 | 1.83 | 0 | miRNAWalker2 validate | -0.17 | 0.00604 | NA | |
47 | hsa-let-7c-5p | CCNB2 | -2.08 | 0 | 1.83 | 0 | miRNAWalker2 validate | -0.2 | 0 | NA | |
48 | hsa-let-7g-5p | CCND1 | -0.25 | 0.0094 | -0.01 | 0.95947 | miRNATAP | -0.42 | 1.0E-5 | NA | |
49 | hsa-miR-106a-5p | CCND1 | 0.68 | 0.00222 | -0.01 | 0.95947 | MirTarget; miRNATAP | -0.29 | 0 | NA | |
50 | hsa-miR-1266-5p | CCND1 | -0.6 | 0.02013 | -0.01 | 0.95947 | MirTarget | -0.14 | 0.00019 | NA | |
51 | hsa-miR-142-3p | CCND1 | 1.13 | 0 | -0.01 | 0.95947 | miRanda | -0.21 | 0 | 23619912 | Transfection of miR-142-3p mimics in colon cancer cells downregulated cyclin D1 expression induced G1 phase cell cycle arrest and elevated the sensitivity of the cells to 5-fluorouracil |
52 | hsa-miR-142-5p | CCND1 | 0.29 | 0.09 | -0.01 | 0.95947 | PITA | -0.19 | 0.00053 | NA | |
53 | hsa-miR-150-5p | CCND1 | -0.24 | 0.33155 | -0.01 | 0.95947 | mirMAP | -0.18 | 0 | NA | |
54 | hsa-miR-155-5p | CCND1 | 0.53 | 0.00249 | -0.01 | 0.95947 | miRNAWalker2 validate | -0.21 | 0.0001 | 26955820 | MicroRNA 155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1 |
55 | hsa-miR-15a-5p | CCND1 | 0.78 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.32 | 5.0E-5 | 22922827 | CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR |
56 | hsa-miR-15b-5p | CCND1 | 0.85 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.2 | 0.00913 | NA | |
57 | hsa-miR-16-1-3p | CCND1 | 0.96 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase | -0.3 | 0 | 22922827; 18483394 | CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR;Truncation in CCND1 mRNA alters miR 16 1 regulation in mantle cell lymphoma; Furthermore we demonstrated that this truncation alters miR-16-1 binding sites and through the use of reporter constructs we were able to show that miR-16-1 regulates CCND1 mRNA expression; This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL |
58 | hsa-miR-16-5p | CCND1 | 0.52 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.36 | 3.0E-5 | 23991964; 22922827; 18483394 | At the molecular level our results further revealed that cyclin D1 expression was negatively regulated by miR-16;CCND1 has been found to be a target of miR-15a and miR-16-1 through analysis of complementary sequences between microRNAs and CCND1 mRNA; Moreover the transcription of CCND1 is suppressed by miR-15a and miR-16-1 via direct binding to the CCND1 3'-untranslated region 3'-UTR;Truncation in CCND1 mRNA alters miR 16 1 regulation in mantle cell lymphoma; Furthermore we demonstrated that this truncation alters miR-16-1 binding sites and through the use of reporter constructs we were able to show that miR-16-1 regulates CCND1 mRNA expression; This study introduces the role of miR-16-1 in the regulation of CCND1 in MCL |
59 | hsa-miR-19a-3p | CCND1 | 1.36 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.13 | 0.00806 | 25985117 | Moreover miR-19a might play inhibitory roles in HCC malignancy via regulating Cyclin D1 expression |
60 | hsa-miR-19b-1-5p | CCND1 | 0.76 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase | -0.2 | 0.00133 | NA | |
61 | hsa-miR-19b-3p | CCND1 | 0.54 | 0.00062 | -0.01 | 0.95947 | miRNATAP | -0.23 | 0.0001 | NA | |
62 | hsa-miR-20a-5p | CCND1 | 1.15 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.15 | 0.0057 | NA | |
63 | hsa-miR-20b-5p | CCND1 | 0.35 | 0.23201 | -0.01 | 0.95947 | MirTarget; miRNATAP | -0.25 | 0 | NA | |
64 | hsa-miR-29b-3p | CCND1 | -0.11 | 0.51126 | -0.01 | 0.95947 | mirMAP | -0.18 | 0.00109 | NA | |
65 | hsa-miR-29c-3p | CCND1 | -2.08 | 0 | -0.01 | 0.95947 | mirMAP | -0.16 | 0.00015 | NA | |
66 | hsa-miR-33a-3p | CCND1 | 0.2 | 0.21234 | -0.01 | 0.95947 | MirTarget | -0.2 | 0.00047 | NA | |
67 | hsa-miR-34a-5p | CCND1 | -0.12 | 0.364 | -0.01 | 0.95947 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.31 | 2.0E-5 | 25792709; 21399894 | This inhibition of proliferation was associated with a decrease in cyclin D1 levels orchestrated principally by HNF-4α a target of miR-34a considered to act as a tumour suppressor in the liver;Quantitative PCR and western analysis confirmed decreased expression of two genes BCL-2 and CCND1 in docetaxel-resistant cells which are both targeted by miR-34a |
68 | hsa-miR-425-5p | CCND1 | 0.93 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate | -0.15 | 0.00573 | NA | |
69 | hsa-miR-497-5p | CCND1 | -0.97 | 0 | -0.01 | 0.95947 | MirTarget; miRNATAP | -0.27 | 5.0E-5 | 21350001 | Raf-1 and Ccnd1 were identified as novel direct targets of miR-195 and miR-497 miR-195/497 expression levels in clinical specimens were found to be correlated inversely with malignancy of breast cancer |
70 | hsa-miR-590-3p | CCND1 | 0.22 | 0.09659 | -0.01 | 0.95947 | mirMAP | -0.24 | 0.00077 | NA | |
71 | hsa-miR-7-1-3p | CCND1 | 1.14 | 0 | -0.01 | 0.95947 | mirMAP | -0.22 | 0.00036 | NA | |
72 | hsa-miR-9-5p | CCND1 | 1.66 | 2.0E-5 | -0.01 | 0.95947 | miRNAWalker2 validate | -0.14 | 0 | NA | |
73 | hsa-miR-92a-3p | CCND1 | 0.99 | 0 | -0.01 | 0.95947 | miRNAWalker2 validate | -0.24 | 0.002 | NA | |
74 | hsa-miR-942-5p | CCND1 | 0.68 | 0 | -0.01 | 0.95947 | MirTarget | -0.23 | 0.00111 | NA | |
75 | hsa-miR-224-3p | CCND2 | 0.5 | 0.00811 | 0.15 | 0.53242 | mirMAP | -0.31 | 0 | NA | |
76 | hsa-miR-27b-3p | CCND3 | -0.73 | 0 | -0.05 | 0.63156 | miRNAWalker2 validate | -0.13 | 0.00016 | NA | |
77 | hsa-miR-125b-5p | CCNE1 | -0.99 | 0 | 1.47 | 0 | miRNAWalker2 validate | -0.28 | 0 | NA | |
78 | hsa-miR-151a-3p | CCNE1 | 0.13 | 0.29527 | 1.47 | 0 | miRNAWalker2 validate | -0.15 | 0.00299 | NA | |
79 | hsa-miR-195-5p | CCNE1 | -1.84 | 0 | 1.47 | 0 | miRNAWalker2 validate; MirTarget; miRNATAP | -0.31 | 0 | 24402230 | Furthermore through qPCR and western blot assays we showed that overexpression of miR-195-5p reduced CCNE1 mRNA and protein levels respectively |
80 | hsa-miR-215-5p | CCNE1 | -0.76 | 6.0E-5 | 1.47 | 0 | miRNAWalker2 validate | -0.13 | 0.0001 | NA | |
81 | hsa-miR-26a-5p | CCNE1 | -1.09 | 0 | 1.47 | 0 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.49 | 0 | 22094936 | Cell cycle regulation and CCNE1 and CDC2 were the only significant overlapping pathway and genes differentially expressed between tumors with high and low levels of miR-26a and EZH2 respectively; Low mRNA levels of EZH2 CCNE1 and CDC2 and high levels of miR-26a are associated with favorable outcome on tamoxifen |
82 | hsa-miR-497-5p | CCNE1 | -0.97 | 0 | 1.47 | 0 | MirTarget; miRNATAP | -0.16 | 0.00018 | 24112607; 25909221; 24909281 | Western blot assays confirmed that overexpression of miR-497 reduced cyclin E1 protein levels; Inhibited cellular growth suppressed cellular migration and invasion and G1 cell cycle arrest were observed upon overexpression of miR-497 in cells possibly by targeting cyclin E1;The effect of simultaneous overexpression of miR-497 and miR-34a on the inhibition of cell proliferation colony formation and tumor growth and the downregulation of cyclin E1 was stronger than the effect of each miRNA alone; The synergistic actions of miR-497 and miR-34a partly correlated with cyclin E1 levels; These results indicate cyclin E1 is downregulated by both miR-497 and miR-34a which synergistically retard the growth of human lung cancer cells;miR 497 suppresses proliferation of human cervical carcinoma HeLa cells by targeting cyclin E1; Furthermore the target effect of miR-497 on the CCNE1 was identified by dual-luciferase reporter assay system qRT-PCR and Western blotting; Over-expressed miR-497 in HeLa cells could suppress cell proliferation by targeting CCNE1 |
83 | hsa-miR-30a-5p | CCNE2 | -1.8 | 0 | 1.24 | 0 | miRNATAP | -0.16 | 5.0E-5 | NA | |
84 | hsa-miR-369-3p | CCNE2 | -1.23 | 0 | 1.24 | 0 | PITA | -0.24 | 0 | NA | |
85 | hsa-miR-23a-3p | CCNH | 0.35 | 6.0E-5 | -0.25 | 0.00055 | MirTarget | -0.14 | 9.0E-5 | NA | |
86 | hsa-let-7a-3p | CDC14A | 0.1 | 0.42376 | -0.49 | 0.00362 | mirMAP | -0.23 | 0.00018 | NA | |
87 | hsa-miR-324-5p | CDC14A | 1.67 | 0 | -0.49 | 0.00362 | miRanda | -0.15 | 0.00028 | NA | |
88 | hsa-miR-338-3p | CDC14A | -0.95 | 0 | -0.49 | 0.00362 | miRanda | -0.13 | 0.00159 | NA | |
89 | hsa-miR-342-3p | CDC14A | 1 | 0 | -0.49 | 0.00362 | miRanda | -0.17 | 0.00019 | NA | |
90 | hsa-miR-424-5p | CDC14A | 1.48 | 0 | -0.49 | 0.00362 | miRNAWalker2 validate; miRTarBase | -0.17 | 5.0E-5 | NA | |
91 | hsa-miR-503-5p | CDC14A | 2.85 | 0 | -0.49 | 0.00362 | miRNAWalker2 validate; miRTarBase | -0.18 | 0 | NA | |
92 | hsa-miR-576-5p | CDC14A | 0.94 | 0 | -0.49 | 0.00362 | mirMAP | -0.25 | 0 | NA | |
93 | hsa-miR-944 | CDC14A | 1.47 | 0 | -0.49 | 0.00362 | mirMAP | -0.1 | 0.00355 | NA | |
94 | hsa-let-7a-3p | CDC14B | 0.1 | 0.42376 | -0.23 | 0.09822 | miRNATAP | -0.18 | 0.00028 | NA | |
95 | hsa-miR-146b-3p | CDC14B | 0.19 | 0.16914 | -0.23 | 0.09822 | miRNATAP | -0.13 | 0.00308 | NA | |
96 | hsa-miR-424-5p | CDC14B | 1.48 | 0 | -0.23 | 0.09822 | MirTarget | -0.14 | 7.0E-5 | NA | |
97 | hsa-miR-450b-5p | CDC14B | 1.26 | 0 | -0.23 | 0.09822 | MirTarget; miRNATAP | -0.11 | 0.00282 | NA | |
98 | hsa-miR-542-3p | CDC14B | 0.64 | 0 | -0.23 | 0.09822 | miRanda | -0.16 | 0.00057 | NA | |
99 | hsa-miR-576-5p | CDC14B | 0.94 | 0 | -0.23 | 0.09822 | mirMAP | -0.15 | 0.00038 | NA | |
100 | hsa-miR-107 | CDC16 | -0.04 | 0.67162 | -0 | 0.96792 | miRanda | -0.2 | 0 | NA | |
101 | hsa-miR-23b-3p | CDC20 | -0.5 | 3.0E-5 | 1.92 | 0 | miRNAWalker2 validate | -0.26 | 1.0E-5 | NA | |
102 | hsa-miR-30a-5p | CDC20 | -1.8 | 0 | 1.92 | 0 | miRNAWalker2 validate | -0.27 | 0 | NA | |
103 | hsa-miR-125a-5p | CDC23 | 0.22 | 0.11955 | 0.25 | 0.00092 | miRanda | -0.1 | 1.0E-5 | NA | |
104 | hsa-let-7e-5p | CDC25A | 0.09 | 0.51287 | 0.86 | 0 | MirTarget; miRNATAP | -0.17 | 0.00016 | NA | |
105 | hsa-miR-195-5p | CDC25A | -1.84 | 0 | 0.86 | 0 | MirTarget; miRNATAP | -0.14 | 8.0E-5 | NA | |
106 | hsa-miR-337-3p | CDC25A | -1.7 | 0 | 0.86 | 0 | mirMAP | -0.19 | 0 | NA | |
107 | hsa-let-7a-5p | CDC25B | -0.44 | 3.0E-5 | 1.62 | 0 | miRNAWalker2 validate | -0.2 | 0.0017 | NA | |
108 | hsa-miR-148a-3p | CDC25B | -0.43 | 0.00954 | 1.62 | 0 | miRNAWalker2 validate; miRNATAP | -0.21 | 0 | 25341915 | Gene CDC25B might be the target gene of miR-148a according to the results of targetscan; CDC25B may be the target gene of miR-148a that plays a role in tumor suppressor |
109 | hsa-miR-27b-3p | CDC25B | -0.73 | 0 | 1.62 | 0 | miRNATAP | -0.23 | 3.0E-5 | NA | |
110 | hsa-miR-15a-5p | CDC27 | 0.78 | 0 | 0.35 | 0 | miRNATAP | -0.1 | 3.0E-5 | NA | |
111 | hsa-miR-497-5p | CDC27 | -0.97 | 0 | 0.35 | 0 | miRNATAP | -0.11 | 0 | NA | |
112 | hsa-miR-199a-5p | CDC6 | -0.36 | 0.04351 | 1.92 | 0 | miRanda | -0.17 | 0 | NA | |
113 | hsa-miR-199b-5p | CDC6 | -1.08 | 0 | 1.92 | 0 | miRanda | -0.23 | 0 | NA | |
114 | hsa-miR-26a-5p | CDC6 | -1.09 | 0 | 1.92 | 0 | miRNAWalker2 validate | -0.33 | 0 | 25100863; 27158389 | Here it is demonstrated that miR26a and miR26b inhibit replication licensing and the proliferation migration and invasion of lung cancer cells by targeting CDC6; The current study suggests that miR26a miR26b and CDC6 and factors regulating their expression represent potential cancer diagnostic and prognostic markers as well as anticancer targets;miR 26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression; Bioinformatics analysis revealed Cdc6 was a target gene of miR-26a; dual-luciferase assay and validation assay showed miR-26a could act on the 3'UTR of Cdc6 to regulate Cdc6 expression; These findings suggest that miR-26a may act on the 3'UTR of Cdc6 to regulate Cdc6 expression which then inhibit the proliferation of ovarian cancer cells and induce their apoptosis |
115 | hsa-miR-199a-5p | CDC7 | -0.36 | 0.04351 | 1.03 | 0 | MirTarget; miRanda | -0.17 | 0 | NA | |
116 | hsa-miR-199b-5p | CDC7 | -1.08 | 0 | 1.03 | 0 | MirTarget; miRanda | -0.16 | 0 | NA | |
117 | hsa-miR-369-3p | CDC7 | -1.23 | 0 | 1.03 | 0 | mirMAP | -0.15 | 0 | NA | |
118 | hsa-miR-10b-5p | CDK2 | -0.58 | 0 | 0.83 | 0 | miRNAWalker2 validate | -0.16 | 0 | NA | |
119 | hsa-miR-495-3p | CDK2 | -1.48 | 0 | 0.83 | 0 | mirMAP | -0.12 | 0 | NA | |
120 | hsa-miR-101-3p | CDK6 | -1.91 | 0 | 0.94 | 0 | mirMAP | -0.33 | 0 | NA | |
121 | hsa-miR-106a-5p | CDK6 | 0.68 | 0.00222 | 0.94 | 0 | mirMAP | -0.27 | 0 | NA | |
122 | hsa-miR-140-3p | CDK6 | -0.97 | 0 | 0.94 | 0 | miRNATAP | -0.27 | 0.00057 | NA | |
123 | hsa-miR-141-3p | CDK6 | 0.73 | 0.00012 | 0.94 | 0 | TargetScan; miRNATAP | -0.14 | 0.00069 | NA | |
124 | hsa-miR-142-5p | CDK6 | 0.29 | 0.09 | 0.94 | 0 | PITA | -0.14 | 0.00345 | NA | |
125 | hsa-miR-146a-5p | CDK6 | -0.02 | 0.90588 | 0.94 | 0 | mirMAP | -0.22 | 1.0E-5 | NA | |
126 | hsa-miR-148a-3p | CDK6 | -0.43 | 0.00954 | 0.94 | 0 | mirMAP | -0.35 | 0 | NA | |
127 | hsa-miR-148a-5p | CDK6 | -1 | 0 | 0.94 | 0 | mirMAP | -0.17 | 6.0E-5 | NA | |
128 | hsa-miR-15a-5p | CDK6 | 0.78 | 0 | 0.94 | 0 | miRNATAP | -0.29 | 3.0E-5 | NA | |
129 | hsa-miR-16-1-3p | CDK6 | 0.96 | 0 | 0.94 | 0 | mirMAP | -0.19 | 0.00047 | NA | |
130 | hsa-miR-16-5p | CDK6 | 0.52 | 0 | 0.94 | 0 | miRNAWalker2 validate; miRTarBase | -0.39 | 0 | NA | |
131 | hsa-miR-191-5p | CDK6 | 0.65 | 0 | 0.94 | 0 | miRNAWalker2 validate; miRTarBase | -0.3 | 0 | NA | |
132 | hsa-miR-195-5p | CDK6 | -1.84 | 0 | 0.94 | 0 | miRNAWalker2 validate; miRTarBase | -0.15 | 0.00222 | 23333942 | Expression of cyclin-dependent kinase 6 and vascular endothelial growth factor was down-regulated by exogenous miR-195 and miR-378 respectively |
133 | hsa-miR-200a-3p | CDK6 | 0.61 | 0.0029 | 0.94 | 0 | miRNATAP | -0.14 | 0.00037 | 24009066 | microRNA 200a is an independent prognostic factor of hepatocellular carcinoma and induces cell cycle arrest by targeting CDK6 |
134 | hsa-miR-200b-3p | CDK6 | 0.07 | 0.68286 | 0.94 | 0 | mirMAP | -0.17 | 0.0002 | NA | |
135 | hsa-miR-20b-5p | CDK6 | 0.35 | 0.23201 | 0.94 | 0 | mirMAP | -0.32 | 0 | 26166554 | The transfection of miR-20b into EJ cells induced G1 phase cell cycle arrest via the decreased expression of cyclin D1 CDK2 and CDK6 without affecting another G1 phase cell cycle regulator cyclin E |
136 | hsa-miR-217 | CDK6 | -1.35 | 0 | 0.94 | 0 | mirMAP | -0.1 | 0.00385 | NA | |
137 | hsa-miR-218-5p | CDK6 | -1.07 | 0 | 0.94 | 0 | miRNAWalker2 validate | -0.16 | 0.00036 | 23996750 | Ectopic expression of miR-218 in HepG2 cells resulted in suppressed cell proliferation and enhanced cell apoptosis as well as the down-regulation of Bmi-1 and CDK6 mRNA and protein expressions P<0.05; The low-expression of miR-218 is correlated with malignant clinicopathological characteristics of HCC and miR-218 may inhibit cell proliferation and promote cell apoptosis by down-regulating Bmi-1 and CDK6 in HCC |
138 | hsa-miR-23b-3p | CDK6 | -0.5 | 3.0E-5 | 0.94 | 0 | mirMAP | -0.19 | 0.00569 | NA | |
139 | hsa-miR-26a-5p | CDK6 | -1.09 | 0 | 0.94 | 0 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.3 | 2.0E-5 | 26314438 | Maxvision immunohistochemistry technique was used to detect the expression level of CDK6 and miR-26a in tissue of 20 ENKTCL cases 10 cases of proliferative lymphadenitis and 10 samples of normal lymph node respectively; The possible role of miR-26a and its target gene CDK6 in genesis and development of ENKTCL were analyzed according to the clinical features of ENKTCL patients; Correlation analysis showed that there was significant negative correlation between miR-26a expression and CDK6 expression r = -0.54 P = 0.04 |
140 | hsa-miR-26b-5p | CDK6 | -0.25 | 0.02852 | 0.94 | 0 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.37 | 0 | NA | |
141 | hsa-miR-27b-3p | CDK6 | -0.73 | 0 | 0.94 | 0 | mirMAP | -0.25 | 0.0001 | NA | |
142 | hsa-miR-27b-5p | CDK6 | 0.58 | 0.00018 | 0.94 | 0 | mirMAP | -0.14 | 0.00915 | NA | |
143 | hsa-miR-29b-3p | CDK6 | -0.11 | 0.51126 | 0.94 | 0 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.23 | 0 | 23245396; 25472644; 26180082; 23591808; 27230400; 20086245 | The IFN-γ-induced G1-arrest of melanoma cells involves down-regulation of CDK6 which we proved to be a direct target of miR-29 in these cells;Moreover miR-29b inhibited the expression of MCL1 and CDK6;Knockdown of NTSR1 increased the expression of miR-29b-1 and miR-129-3p which were responsible for the decreased CDK6 expression;Here we have identified the oncogene cyclin-dependent protein kinase 6 CDK6 as a direct target of miR-29b in lung cancer;MiR 29b suppresses the proliferation and migration of osteosarcoma cells by targeting CDK6; In this study we investigated the role of miR-29b as a novel regulator of CDK6 using bioinformatics methods; We demonstrated that CDK6 can be downregulated by miR-29b via binding to the 3'-UTR region in osteosarcoma cells; Furthermore we identified an inverse correlation between miR-29b and CDK6 protein levels in osteosarcoma tissues; The results revealed that miR-29b acts as a tumor suppressor of osteosarcoma by targeting CDK6 in the proliferation and migration processes;microRNA expression profile and identification of miR 29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma; Furthermore we demonstrate miR-29 inhibition of CDK6 protein and mRNA levels by direct binding to 3'-untranslated region; Inverse correlation between miR-29 and CDK6 was observed in MCL |
144 | hsa-miR-29c-3p | CDK6 | -2.08 | 0 | 0.94 | 0 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.26 | 0 | 26396669 | Furthermore through qPCR and Western blot assays confirmed that overexpression of miR-29c reduced CDK6 mRNA and protein levels; miR-29c could inhibit the proliferation migration and invasion of bladder cancer cells via regulating CDK6 |
145 | hsa-miR-30a-3p | CDK6 | -2.26 | 0 | 0.94 | 0 | miRNAWalker2 validate; miRTarBase; mirMAP | -0.14 | 0.00032 | NA | |
146 | hsa-miR-30a-5p | CDK6 | -1.8 | 0 | 0.94 | 0 | mirMAP | -0.24 | 0 | NA | |
147 | hsa-miR-30b-5p | CDK6 | -0.4 | 0.00347 | 0.94 | 0 | mirMAP | -0.43 | 0 | NA | |
148 | hsa-miR-30c-5p | CDK6 | 0.02 | 0.88637 | 0.94 | 0 | mirMAP | -0.34 | 0 | NA | |
149 | hsa-miR-30d-3p | CDK6 | -0.58 | 0 | 0.94 | 0 | mirMAP | -0.5 | 0 | NA | |
150 | hsa-miR-30d-5p | CDK6 | -0.38 | 0.00017 | 0.94 | 0 | mirMAP | -0.48 | 0 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL CYCLE | 76 | 1316 | 1.863e-77 | 8.667e-74 |
2 | CELL CYCLE PROCESS | 72 | 1081 | 3.725e-76 | 8.667e-73 |
3 | MITOTIC CELL CYCLE | 65 | 766 | 2.121e-73 | 3.29e-70 |
4 | REGULATION OF CELL CYCLE | 68 | 949 | 1.165e-72 | 1.355e-69 |
5 | REGULATION OF MITOTIC CELL CYCLE | 47 | 468 | 1.985e-53 | 1.847e-50 |
6 | REGULATION OF CELL CYCLE PHASE TRANSITION | 40 | 321 | 1.284e-48 | 9.96e-46 |
7 | REGULATION OF CELL CYCLE PROCESS | 46 | 558 | 4.052e-48 | 2.693e-45 |
8 | CELL CYCLE PHASE TRANSITION | 37 | 255 | 2.677e-47 | 1.557e-44 |
9 | NEGATIVE REGULATION OF CELL CYCLE | 42 | 433 | 1.618e-46 | 8.368e-44 |
10 | CELL CYCLE CHECKPOINT | 33 | 194 | 2.285e-44 | 1.063e-41 |
11 | NEGATIVE REGULATION OF MITOTIC CELL CYCLE | 32 | 199 | 3.931e-42 | 1.663e-39 |
12 | NEGATIVE REGULATION OF CELL CYCLE PROCESS | 32 | 214 | 4.69e-41 | 1.819e-38 |
13 | MITOTIC CELL CYCLE CHECKPOINT | 28 | 139 | 1.096e-39 | 3.922e-37 |
14 | CELL DIVISION | 37 | 460 | 1.695e-37 | 5.632e-35 |
15 | NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 26 | 146 | 2.712e-35 | 8.413e-33 |
16 | REGULATION OF TRANSFERASE ACTIVITY | 44 | 946 | 6.733e-35 | 1.958e-32 |
17 | POSITIVE REGULATION OF CELL CYCLE | 32 | 332 | 1.054e-34 | 2.885e-32 |
18 | REGULATION OF PROTEIN MODIFICATION PROCESS | 52 | 1710 | 4.089e-33 | 1.057e-30 |
19 | CELL CYCLE G1 S PHASE TRANSITION | 23 | 111 | 7.58e-33 | 1.763e-30 |
20 | G1 S TRANSITION OF MITOTIC CELL CYCLE | 23 | 111 | 7.58e-33 | 1.763e-30 |
21 | DNA INTEGRITY CHECKPOINT | 24 | 146 | 1.162e-31 | 2.575e-29 |
22 | POSITIVE REGULATION OF CELL CYCLE PROCESS | 27 | 247 | 1.216e-30 | 2.571e-28 |
23 | MITOTIC NUCLEAR DIVISION | 30 | 361 | 1.704e-30 | 3.447e-28 |
24 | NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 20 | 98 | 1.912e-28 | 3.707e-26 |
25 | REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 22 | 147 | 4.512e-28 | 8.397e-26 |
26 | ORGANELLE FISSION | 31 | 496 | 1.006e-27 | 1.801e-25 |
27 | G1 DNA DAMAGE CHECKPOINT | 18 | 73 | 2.726e-27 | 4.68e-25 |
28 | REGULATION OF ORGANELLE ORGANIZATION | 41 | 1178 | 2.816e-27 | 4.68e-25 |
29 | SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE | 19 | 96 | 9.088e-27 | 1.458e-24 |
30 | MITOTIC DNA INTEGRITY CHECKPOINT | 19 | 100 | 2.114e-26 | 3.278e-24 |
31 | CELLULAR RESPONSE TO DNA DAMAGE STIMULUS | 33 | 720 | 2.886e-25 | 4.332e-23 |
32 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 38 | 1087 | 3.924e-25 | 5.706e-23 |
33 | REGULATION OF CELL DIVISION | 24 | 272 | 6.246e-25 | 8.807e-23 |
34 | POSITIVE REGULATION OF CELL CYCLE ARREST | 17 | 85 | 4.256e-24 | 5.824e-22 |
35 | REGULATION OF CELL CYCLE ARREST | 18 | 108 | 6.143e-24 | 8.166e-22 |
36 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 30 | 616 | 1.264e-23 | 1.634e-21 |
37 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 40 | 1492 | 2.664e-22 | 3.35e-20 |
38 | NEGATIVE REGULATION OF TRANSFERASE ACTIVITY | 24 | 351 | 2.824e-22 | 3.446e-20 |
39 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 36 | 1135 | 2.888e-22 | 3.446e-20 |
40 | REGULATION OF NUCLEAR DIVISION | 19 | 163 | 3.852e-22 | 4.48e-20 |
41 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 41 | 1618 | 5.183e-22 | 5.882e-20 |
42 | POSITIVE REGULATION OF TRANSFERASE ACTIVITY | 28 | 616 | 3.383e-21 | 3.748e-19 |
43 | SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 17 | 127 | 6.168e-21 | 6.674e-19 |
44 | REGULATION OF CHROMOSOME ORGANIZATION | 21 | 278 | 2.04e-20 | 2.158e-18 |
45 | CELL CYCLE G2 M PHASE TRANSITION | 17 | 138 | 2.678e-20 | 2.769e-18 |
46 | REGULATION OF SISTER CHROMATID SEGREGATION | 14 | 67 | 2.8e-20 | 2.832e-18 |
47 | REGULATION OF KINASE ACTIVITY | 29 | 776 | 1.233e-19 | 1.22e-17 |
48 | CHROMOSOME ORGANIZATION | 32 | 1009 | 1.261e-19 | 1.222e-17 |
49 | REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 15 | 97 | 1.486e-19 | 1.411e-17 |
50 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 29 | 829 | 7.407e-19 | 6.893e-17 |
51 | REGULATION OF CHROMOSOME SEGREGATION | 14 | 85 | 1.021e-18 | 9.318e-17 |
52 | CELLULAR RESPONSE TO STRESS | 37 | 1565 | 1.291e-18 | 1.156e-16 |
53 | REGULATION OF PROTEIN CATABOLIC PROCESS | 22 | 393 | 1.468e-18 | 1.289e-16 |
54 | POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 11 | 36 | 3.44e-18 | 2.964e-16 |
55 | POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION | 21 | 360 | 4.263e-18 | 3.543e-16 |
56 | REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 23 | 470 | 4.264e-18 | 3.543e-16 |
57 | CELL CYCLE ARREST | 16 | 154 | 6.204e-18 | 5.065e-16 |
58 | POSITIVE REGULATION OF CELL DEATH | 25 | 605 | 6.485e-18 | 5.202e-16 |
59 | REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 19 | 274 | 8.095e-18 | 6.384e-16 |
60 | DNA METABOLIC PROCESS | 27 | 758 | 1.003e-17 | 7.78e-16 |
61 | ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS | 13 | 77 | 1.346e-17 | 1.027e-15 |
62 | REGULATION OF LIGASE ACTIVITY | 15 | 130 | 1.45e-17 | 1.088e-15 |
63 | POSITIVE REGULATION OF ORGANELLE ORGANIZATION | 24 | 573 | 2.476e-17 | 1.8e-15 |
64 | REGULATION OF PROTEOLYSIS | 26 | 711 | 2.446e-17 | 1.8e-15 |
65 | REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 29 | 3.001e-17 | 2.116e-15 |
66 | POSITIVE REGULATION OF PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 10 | 29 | 3.001e-17 | 2.116e-15 |
67 | REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY | 11 | 43 | 3.213e-17 | 2.231e-15 |
68 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 30 | 1079 | 8.958e-17 | 6.041e-15 |
69 | POSITIVE REGULATION OF PROTEOLYSIS | 20 | 363 | 8.931e-17 | 6.041e-15 |
70 | REGULATION OF CELLULAR PROTEIN LOCALIZATION | 23 | 552 | 1.44e-16 | 9.573e-15 |
71 | CHROMOSOME SEGREGATION | 18 | 272 | 1.487e-16 | 9.747e-15 |
72 | NUCLEAR CHROMOSOME SEGREGATION | 17 | 228 | 1.525e-16 | 9.853e-15 |
73 | REGULATION OF CELL PROLIFERATION | 34 | 1496 | 1.845e-16 | 1.176e-14 |
74 | POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 16 | 192 | 2.189e-16 | 1.376e-14 |
75 | POSITIVE REGULATION OF MITOTIC CELL CYCLE | 14 | 123 | 2.273e-16 | 1.41e-14 |
76 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 34 | 1518 | 2.864e-16 | 1.753e-14 |
77 | REGULATION OF CATABOLIC PROCESS | 25 | 731 | 5.408e-16 | 3.268e-14 |
78 | SISTER CHROMATID SEGREGATION | 15 | 176 | 1.459e-15 | 8.702e-14 |
79 | POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 17 | 263 | 1.668e-15 | 9.822e-14 |
80 | POSITIVE REGULATION OF LIGASE ACTIVITY | 13 | 110 | 1.731e-15 | 1.007e-13 |
81 | POSITIVE REGULATION OF INTRACELLULAR TRANSPORT | 19 | 370 | 2.096e-15 | 1.204e-13 |
82 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 35 | 1791 | 5.719e-15 | 3.245e-13 |
83 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 35 | 1805 | 7.239e-15 | 4.058e-13 |
84 | REGULATION OF MEMBRANE PERMEABILITY | 11 | 70 | 1.098e-14 | 6.085e-13 |
85 | POSITIVE REGULATION OF GENE EXPRESSION | 34 | 1733 | 1.472e-14 | 8.059e-13 |
86 | DNA REPLICATION | 15 | 208 | 1.763e-14 | 9.54e-13 |
87 | PROTEIN PHOSPHORYLATION | 26 | 944 | 2.115e-14 | 1.131e-12 |
88 | PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 13 | 134 | 2.373e-14 | 1.255e-12 |
89 | REGULATION OF PROTEIN UBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 12 | 103 | 2.675e-14 | 1.398e-12 |
90 | POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 28 | 1152 | 3.678e-14 | 1.902e-12 |
91 | REGULATION OF CELL DEATH | 31 | 1472 | 4.993e-14 | 2.537e-12 |
92 | PROTEASOMAL PROTEIN CATABOLIC PROCESS | 16 | 271 | 5.016e-14 | 2.537e-12 |
93 | POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION | 20 | 514 | 6.675e-14 | 3.339e-12 |
94 | REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 16 | 280 | 8.326e-14 | 4.121e-12 |
95 | RESPONSE TO ABIOTIC STIMULUS | 26 | 1024 | 1.404e-13 | 6.874e-12 |
96 | POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 14 | 196 | 1.609e-13 | 7.801e-12 |
97 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 20 | 541 | 1.732e-13 | 8.222e-12 |
98 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 20 | 541 | 1.732e-13 | 8.222e-12 |
99 | MITOCHONDRIAL MEMBRANE ORGANIZATION | 11 | 92 | 2.524e-13 | 1.186e-11 |
100 | CELLULAR RESPONSE TO UV | 10 | 66 | 2.772e-13 | 1.29e-11 |
101 | INTRACELLULAR SIGNAL TRANSDUCTION | 31 | 1572 | 2.905e-13 | 1.338e-11 |
102 | NEGATIVE REGULATION OF CHROMOSOME SEGREGATION | 8 | 28 | 2.934e-13 | 1.339e-11 |
103 | POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION | 10 | 68 | 3.793e-13 | 1.713e-11 |
104 | DNA REPLICATION INITIATION | 8 | 29 | 4.038e-13 | 1.806e-11 |
105 | POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY | 13 | 171 | 5.669e-13 | 2.512e-11 |
106 | CELL DEATH | 25 | 1001 | 6.691e-13 | 2.937e-11 |
107 | CELLULAR RESPONSE TO RADIATION | 12 | 137 | 8.625e-13 | 3.751e-11 |
108 | CELL PROLIFERATION | 21 | 672 | 9.997e-13 | 4.307e-11 |
109 | NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 12 | 139 | 1.027e-12 | 4.382e-11 |
110 | POSITIVE REGULATION OF CATABOLIC PROCESS | 17 | 395 | 1.282e-12 | 5.423e-11 |
111 | POSITIVE REGULATION OF FIBROBLAST PROLIFERATION | 9 | 53 | 1.537e-12 | 6.442e-11 |
112 | REGULATION OF DNA METABOLIC PROCESS | 16 | 340 | 1.637e-12 | 6.802e-11 |
113 | REGULATION OF PROTEIN LOCALIZATION | 24 | 950 | 1.689e-12 | 6.894e-11 |
114 | NEGATIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 8 | 34 | 1.678e-12 | 6.894e-11 |
115 | SISTER CHROMATID COHESION | 11 | 111 | 2.078e-12 | 8.406e-11 |
116 | REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS | 12 | 148 | 2.177e-12 | 8.723e-11 |
117 | REGULATION OF INTRACELLULAR TRANSPORT | 20 | 621 | 2.193e-12 | 8.723e-11 |
118 | REGULATION OF FIBROBLAST PROLIFERATION | 10 | 81 | 2.339e-12 | 9.225e-11 |
119 | DNA REPAIR | 18 | 480 | 2.616e-12 | 1.023e-10 |
120 | NEGATIVE REGULATION OF PHOSPHORYLATION | 17 | 422 | 3.68e-12 | 1.427e-10 |
121 | POSITIVE REGULATION OF CELL PROLIFERATION | 22 | 814 | 4.64e-12 | 1.784e-10 |
122 | NEGATIVE REGULATION OF CELL DIVISION | 9 | 60 | 5e-12 | 1.907e-10 |
123 | REGULATION OF DNA REPLICATION | 12 | 161 | 5.931e-12 | 2.244e-10 |
124 | RESPONSE TO OXYGEN LEVELS | 15 | 311 | 6.132e-12 | 2.301e-10 |
125 | CELLULAR RESPONSE TO LIGHT STIMULUS | 10 | 91 | 7.725e-12 | 2.875e-10 |
126 | RESPONSE TO UV | 11 | 126 | 8.457e-12 | 3.123e-10 |
127 | PEPTIDYL AMINO ACID MODIFICATION | 22 | 841 | 8.789e-12 | 3.195e-10 |
128 | PHOSPHORYLATION | 26 | 1228 | 8.777e-12 | 3.195e-10 |
129 | POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION | 12 | 167 | 9.149e-12 | 3.3e-10 |
130 | REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION | 11 | 128 | 1.006e-11 | 3.6e-10 |
131 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 24 | 1036 | 1.051e-11 | 3.705e-10 |
132 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 24 | 1036 | 1.051e-11 | 3.705e-10 |
133 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 32 | 1929 | 1.111e-11 | 3.887e-10 |
134 | PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL | 22 | 873 | 1.818e-11 | 6.314e-10 |
135 | REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE | 7 | 27 | 2.07e-11 | 7.134e-10 |
136 | NEGATIVE REGULATION OF NUCLEAR DIVISION | 8 | 46 | 2.31e-11 | 7.904e-10 |
137 | REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 12 | 181 | 2.362e-11 | 8.023e-10 |
138 | RESPONSE TO RADIATION | 16 | 413 | 3.051e-11 | 1.029e-09 |
139 | POSITIVE REGULATION OF CELL COMMUNICATION | 28 | 1532 | 3.623e-11 | 1.213e-09 |
140 | NEGATIVE REGULATION OF CELL PROLIFERATION | 19 | 643 | 3.732e-11 | 1.241e-09 |
141 | POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 23 | 1004 | 3.91e-11 | 1.29e-09 |
142 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 30 | 1784 | 4.507e-11 | 1.477e-09 |
143 | POSITIVE REGULATION OF CHROMOSOME ORGANIZATION | 11 | 150 | 5.691e-11 | 1.852e-09 |
144 | PROTEIN CATABOLIC PROCESS | 18 | 579 | 5.782e-11 | 1.868e-09 |
145 | NEGATIVE REGULATION OF DNA REPLICATION | 8 | 55 | 1.044e-10 | 3.35e-09 |
146 | CELLULAR RESPONSE TO ABIOTIC STIMULUS | 13 | 263 | 1.306e-10 | 4.162e-09 |
147 | POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 7 | 36 | 1.884e-10 | 5.965e-09 |
148 | REGULATION OF MITOCHONDRION ORGANIZATION | 12 | 218 | 2.06e-10 | 6.477e-09 |
149 | MITOTIC SISTER CHROMATID SEGREGATION | 9 | 91 | 2.374e-10 | 7.413e-09 |
150 | MITOCHONDRIAL TRANSPORT | 11 | 177 | 3.386e-10 | 1.05e-08 |
151 | APOPTOTIC SIGNALING PATHWAY | 13 | 289 | 4.173e-10 | 1.286e-08 |
152 | DNA DEPENDENT DNA REPLICATION | 9 | 99 | 5.095e-10 | 1.56e-08 |
153 | MEIOTIC CELL CYCLE | 11 | 186 | 5.748e-10 | 1.748e-08 |
154 | RESPONSE TO DRUG | 15 | 431 | 5.949e-10 | 1.798e-08 |
155 | REGULATION OF CELLULAR LOCALIZATION | 24 | 1277 | 7.675e-10 | 2.304e-08 |
156 | INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE | 8 | 71 | 8.617e-10 | 2.57e-08 |
157 | NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS | 26 | 1517 | 8.975e-10 | 2.66e-08 |
158 | NEGATIVE REGULATION OF KINASE ACTIVITY | 12 | 250 | 9.907e-10 | 2.903e-08 |
159 | SPINDLE CHECKPOINT | 6 | 25 | 1.011e-09 | 2.903e-08 |
160 | DIGESTIVE SYSTEM DEVELOPMENT | 10 | 148 | 9.992e-10 | 2.903e-08 |
161 | REGULATION OF CELLULAR RESPONSE TO STRESS | 18 | 691 | 9.952e-10 | 2.903e-08 |
162 | POSITIVE REGULATION OF CHROMOSOME SEGREGATION | 6 | 25 | 1.011e-09 | 2.903e-08 |
163 | REPLICATIVE SENESCENCE | 5 | 12 | 1.136e-09 | 3.243e-08 |
164 | RESPONSE TO LIPID | 20 | 888 | 1.261e-09 | 3.576e-08 |
165 | INTRINSIC APOPTOTIC SIGNALING PATHWAY | 10 | 152 | 1.297e-09 | 3.635e-08 |
166 | MEIOTIC CELL CYCLE PROCESS | 10 | 152 | 1.297e-09 | 3.635e-08 |
167 | NEGATIVE REGULATION OF DNA METABOLIC PROCESS | 9 | 111 | 1.425e-09 | 3.971e-08 |
168 | PROTEIN K11 LINKED UBIQUITINATION | 6 | 27 | 1.677e-09 | 4.646e-08 |
169 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 21 | 1008 | 1.82e-09 | 5.011e-08 |
170 | POSITIVE REGULATION OF STEM CELL DIFFERENTIATION | 7 | 50 | 2.146e-09 | 5.872e-08 |
171 | PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS | 29 | 1977 | 2.643e-09 | 7.192e-08 |
172 | POSITIVE REGULATION OF KINASE ACTIVITY | 15 | 482 | 2.738e-09 | 7.406e-08 |
173 | POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 9 | 121 | 3.074e-09 | 8.269e-08 |
174 | POSITIVE REGULATION OF TRANSPORT | 20 | 936 | 3.108e-09 | 8.312e-08 |
175 | RESPONSE TO STEROID HORMONE | 15 | 497 | 4.142e-09 | 1.101e-07 |
176 | NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 9 | 126 | 4.402e-09 | 1.164e-07 |
177 | NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION | 17 | 684 | 6.257e-09 | 1.645e-07 |
178 | REGULATION OF APOPTOTIC SIGNALING PATHWAY | 13 | 363 | 6.591e-09 | 1.723e-07 |
179 | POSITIVE REGULATION OF CELL DIVISION | 9 | 132 | 6.639e-09 | 1.726e-07 |
180 | POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 34 | 7.435e-09 | 1.922e-07 |
181 | RESPONSE TO ENDOGENOUS STIMULUS | 24 | 1450 | 9.45e-09 | 2.429e-07 |
182 | REGULATION OF MICROTUBULE BASED PROCESS | 11 | 243 | 9.545e-09 | 2.44e-07 |
183 | NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION | 8 | 96 | 9.825e-09 | 2.498e-07 |
184 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 19 | 917 | 1.36e-08 | 3.42e-07 |
185 | POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 8 | 100 | 1.359e-08 | 3.42e-07 |
186 | NEGATIVE REGULATION OF ORGANELLE ORGANIZATION | 13 | 387 | 1.411e-08 | 3.53e-07 |
187 | CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND | 14 | 465 | 1.485e-08 | 3.695e-07 |
188 | MACROMOLECULE CATABOLIC PROCESS | 19 | 926 | 1.59e-08 | 3.936e-07 |
189 | REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 10 | 207 | 2.538e-08 | 6.249e-07 |
190 | NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS | 8 | 109 | 2.687e-08 | 6.581e-07 |
191 | REGULATION OF CYTOSKELETON ORGANIZATION | 14 | 502 | 3.866e-08 | 9.417e-07 |
192 | NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION | 8 | 115 | 4.096e-08 | 9.84e-07 |
193 | PROTEIN SUMOYLATION | 8 | 115 | 4.096e-08 | 9.84e-07 |
194 | RESPONSE TO LIGHT STIMULUS | 11 | 280 | 4.103e-08 | 9.84e-07 |
195 | RESPONSE TO ESTROGEN | 10 | 218 | 4.143e-08 | 9.885e-07 |
196 | POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT | 11 | 282 | 4.412e-08 | 1.047e-06 |
197 | REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT | 10 | 220 | 4.515e-08 | 1.067e-06 |
198 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 11 | 285 | 4.914e-08 | 1.155e-06 |
199 | RESPONSE TO HORMONE | 18 | 893 | 5.304e-08 | 1.24e-06 |
200 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 26 | 1848 | 5.435e-08 | 1.265e-06 |
201 | POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY | 11 | 289 | 5.663e-08 | 1.311e-06 |
202 | REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION | 9 | 178 | 8.938e-08 | 2.059e-06 |
203 | PROTEIN UBIQUITINATION | 15 | 629 | 9.357e-08 | 2.145e-06 |
204 | MEIOSIS I | 7 | 88 | 1.192e-07 | 2.718e-06 |
205 | POSITIVE REGULATION OF DNA METABOLIC PROCESS | 9 | 185 | 1.243e-07 | 2.822e-06 |
206 | REPRODUCTION | 21 | 1297 | 1.439e-07 | 3.251e-06 |
207 | RESPONSE TO GROWTH FACTOR | 13 | 475 | 1.542e-07 | 3.465e-06 |
208 | GLAND DEVELOPMENT | 12 | 395 | 1.585e-07 | 3.545e-06 |
209 | SMAD PROTEIN SIGNAL TRANSDUCTION | 6 | 56 | 1.661e-07 | 3.699e-06 |
210 | POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 10 | 258 | 2.001e-07 | 4.434e-06 |
211 | NEGATIVE REGULATION OF PROTEOLYSIS | 11 | 329 | 2.093e-07 | 4.616e-06 |
212 | NEGATIVE REGULATION OF CELL DEATH | 17 | 872 | 2.119e-07 | 4.651e-06 |
213 | PROTEOLYSIS | 20 | 1208 | 2.131e-07 | 4.656e-06 |
214 | REGULATION OF CELL CYCLE G2 M PHASE TRANSITION | 6 | 59 | 2.281e-07 | 4.96e-06 |
215 | MITOTIC CELL CYCLE ARREST | 4 | 13 | 2.427e-07 | 5.253e-06 |
216 | RESPONSE TO IONIZING RADIATION | 8 | 145 | 2.478e-07 | 5.337e-06 |
217 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 7 | 99 | 2.687e-07 | 5.736e-06 |
218 | REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 7 | 99 | 2.687e-07 | 5.736e-06 |
219 | PEPTIDYL SERINE MODIFICATION | 8 | 148 | 2.899e-07 | 6.16e-06 |
220 | G2 DNA DAMAGE CHECKPOINT | 5 | 33 | 3.166e-07 | 6.696e-06 |
221 | POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION | 4 | 14 | 3.386e-07 | 7.066e-06 |
222 | POSITIVE REGULATION OF MITOTIC METAPHASE ANAPHASE TRANSITION | 4 | 14 | 3.386e-07 | 7.066e-06 |
223 | POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE | 4 | 14 | 3.386e-07 | 7.066e-06 |
224 | NEGATIVE REGULATION OF GENE EXPRESSION | 22 | 1493 | 3.473e-07 | 7.214e-06 |
225 | NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS | 6 | 64 | 3.73e-07 | 7.714e-06 |
226 | REGULATION OF BINDING | 10 | 283 | 4.689e-07 | 9.654e-06 |
227 | REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION | 6 | 67 | 4.913e-07 | 1.007e-05 |
228 | REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 9 | 218 | 4.991e-07 | 1.019e-05 |
229 | POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 8 | 162 | 5.781e-07 | 1.175e-05 |
230 | MESENCHYME MORPHOGENESIS | 5 | 38 | 6.581e-07 | 1.331e-05 |
231 | REGULATION OF STEM CELL DIFFERENTIATION | 7 | 113 | 6.634e-07 | 1.336e-05 |
232 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 15 | 740 | 7.447e-07 | 1.494e-05 |
233 | REGULATION OF INTRACELLULAR PROTEIN TRANSPORT | 11 | 381 | 8.944e-07 | 1.786e-05 |
234 | REGULATION OF DNA DEPENDENT DNA REPLICATION | 5 | 41 | 9.724e-07 | 1.934e-05 |
235 | REGULATION OF CELLULAR RESPONSE TO HEAT | 6 | 76 | 1.043e-06 | 2.065e-05 |
236 | REGULATION OF RESPONSE TO STRESS | 21 | 1468 | 1.108e-06 | 2.184e-05 |
237 | PEPTIDYL LYSINE MODIFICATION | 10 | 312 | 1.139e-06 | 2.236e-05 |
238 | REGULATION OF CELL GROWTH | 11 | 391 | 1.152e-06 | 2.252e-05 |
239 | REGULATION OF CYTOPLASMIC TRANSPORT | 12 | 481 | 1.28e-06 | 2.492e-05 |
240 | POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 4 | 19 | 1.289e-06 | 2.5e-05 |
241 | PROTEIN LOCALIZATION TO CHROMOSOME | 5 | 45 | 1.564e-06 | 3.019e-05 |
242 | POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS | 7 | 129 | 1.622e-06 | 3.119e-05 |
243 | ORGAN REGENERATION | 6 | 83 | 1.757e-06 | 3.363e-05 |
244 | GROWTH | 11 | 410 | 1.826e-06 | 3.483e-05 |
245 | POSITIVE REGULATION OF CHROMATIN MODIFICATION | 6 | 85 | 2.021e-06 | 3.838e-05 |
246 | POSITIVE REGULATION OF DNA REPLICATION | 6 | 86 | 2.165e-06 | 4.086e-05 |
247 | POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 5 | 48 | 2.169e-06 | 4.086e-05 |
248 | REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 10 | 337 | 2.276e-06 | 4.27e-05 |
249 | CELLULAR RESPONSE TO EXTERNAL STIMULUS | 9 | 264 | 2.444e-06 | 4.548e-05 |
250 | AGING | 9 | 264 | 2.444e-06 | 4.548e-05 |
251 | RESPONSE TO GAMMA RADIATION | 5 | 50 | 2.665e-06 | 4.941e-05 |
252 | POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION | 5 | 51 | 2.945e-06 | 5.437e-05 |
253 | MICROTUBULE CYTOSKELETON ORGANIZATION | 10 | 348 | 3.03e-06 | 5.573e-05 |
254 | NEGATIVE REGULATION OF CATABOLIC PROCESS | 8 | 203 | 3.148e-06 | 5.767e-05 |
255 | CELLULAR RESPONSE TO OXYGEN LEVELS | 7 | 143 | 3.228e-06 | 5.89e-05 |
256 | CELLULAR RESPONSE TO IONIZING RADIATION | 5 | 52 | 3.247e-06 | 5.901e-05 |
257 | REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS | 7 | 145 | 3.54e-06 | 6.409e-05 |
258 | INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR | 5 | 53 | 3.572e-06 | 6.443e-05 |
259 | REGULATION OF DNA BIOSYNTHETIC PROCESS | 6 | 94 | 3.646e-06 | 6.549e-05 |
260 | RESPONSE TO ESTRADIOL | 7 | 146 | 3.705e-06 | 6.631e-05 |
261 | CELLULAR CATABOLIC PROCESS | 19 | 1322 | 3.751e-06 | 6.688e-05 |
262 | REGULATION OF GROWTH | 13 | 633 | 3.841e-06 | 6.821e-05 |
263 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 6 | 95 | 3.878e-06 | 6.86e-05 |
264 | HISTONE PHOSPHORYLATION | 4 | 25 | 4.124e-06 | 7.269e-05 |
265 | RESPONSE TO ALCOHOL | 10 | 362 | 4.298e-06 | 7.547e-05 |
266 | POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS | 6 | 98 | 4.647e-06 | 8.129e-05 |
267 | RESPONSE TO NITROGEN COMPOUND | 15 | 859 | 4.682e-06 | 8.158e-05 |
268 | REGULATION OF CHROMATIN ORGANIZATION | 7 | 152 | 4.836e-06 | 8.397e-05 |
269 | CELLULAR RESPONSE TO LIPID | 11 | 457 | 5.169e-06 | 8.941e-05 |
270 | CELLULAR RESPONSE TO HORMONE STIMULUS | 12 | 552 | 5.282e-06 | 9.103e-05 |
271 | CELLULAR RESPONSE TO STEROID HORMONE STIMULUS | 8 | 218 | 5.33e-06 | 9.152e-05 |
272 | CELLULAR MACROMOLECULE LOCALIZATION | 18 | 1234 | 5.783e-06 | 9.894e-05 |
273 | CHROMATIN ORGANIZATION | 13 | 663 | 6.339e-06 | 0.000108 |
274 | RHYTHMIC PROCESS | 9 | 298 | 6.543e-06 | 0.000111 |
275 | CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES | 6 | 104 | 6.559e-06 | 0.000111 |
276 | REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION | 5 | 60 | 6.636e-06 | 0.0001119 |
277 | REGENERATION | 7 | 161 | 7.063e-06 | 0.0001182 |
278 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 19 | 1381 | 7.053e-06 | 0.0001182 |
279 | REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 7 | 162 | 7.356e-06 | 0.0001222 |
280 | TISSUE DEVELOPMENT | 20 | 1518 | 7.349e-06 | 0.0001222 |
281 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 8 | 229 | 7.647e-06 | 0.0001253 |
282 | NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE | 4 | 29 | 7.64e-06 | 0.0001253 |
283 | REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 4 | 29 | 7.64e-06 | 0.0001253 |
284 | REGULATION OF HEART MORPHOGENESIS | 4 | 29 | 7.64e-06 | 0.0001253 |
285 | SOMITOGENESIS | 5 | 62 | 7.809e-06 | 0.000127 |
286 | POSITIVE REGULATION OF NUCLEAR DIVISION | 5 | 62 | 7.809e-06 | 0.000127 |
287 | PROTEIN COMPLEX SUBUNIT ORGANIZATION | 20 | 1527 | 8.024e-06 | 0.0001301 |
288 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 17 | 1142 | 8.431e-06 | 0.0001362 |
289 | IMMUNE SYSTEM DEVELOPMENT | 12 | 582 | 9.015e-06 | 0.0001451 |
290 | NEGATIVE REGULATION OF CELL GROWTH | 7 | 170 | 1.008e-05 | 0.0001618 |
291 | NOTCH SIGNALING PATHWAY | 6 | 114 | 1.113e-05 | 0.000178 |
292 | POSITIVE REGULATION OF NEURON DEATH | 5 | 67 | 1.146e-05 | 0.0001819 |
293 | CELL AGING | 5 | 67 | 1.146e-05 | 0.0001819 |
294 | PROTEIN POLYUBIQUITINATION | 8 | 243 | 1.178e-05 | 0.0001864 |
295 | REGULATION OF PROTEIN EXPORT FROM NUCLEUS | 4 | 33 | 1.299e-05 | 0.0002049 |
296 | MITOTIC SPINDLE ORGANIZATION | 5 | 69 | 1.324e-05 | 0.000206 |
297 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 11 | 505 | 1.322e-05 | 0.000206 |
298 | NEGATIVE REGULATION OF CELLULAR SENESCENCE | 3 | 11 | 1.324e-05 | 0.000206 |
299 | ACTIVATION OF MAPKKK ACTIVITY | 3 | 11 | 1.324e-05 | 0.000206 |
300 | EPITHELIUM DEVELOPMENT | 15 | 945 | 1.463e-05 | 0.0002269 |
301 | RESPONSE TO KETONE | 7 | 182 | 1.571e-05 | 0.0002428 |
302 | DEVELOPMENTAL GROWTH | 9 | 333 | 1.589e-05 | 0.0002448 |
303 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 13 | 724 | 1.619e-05 | 0.0002486 |
304 | REGULATION OF PROTEIN IMPORT | 7 | 183 | 1.628e-05 | 0.0002491 |
305 | RESPONSE TO MINERALOCORTICOID | 4 | 35 | 1.651e-05 | 0.000251 |
306 | RESPONSE TO IRON ION | 4 | 35 | 1.651e-05 | 0.000251 |
307 | CELLULAR RESPONSE TO OXIDATIVE STRESS | 7 | 184 | 1.686e-05 | 0.0002555 |
308 | REGULATION OF MACROPHAGE CYTOKINE PRODUCTION | 3 | 12 | 1.76e-05 | 0.0002641 |
309 | POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS | 3 | 12 | 1.76e-05 | 0.0002641 |
310 | MITOTIC SISTER CHROMATID COHESION | 3 | 12 | 1.76e-05 | 0.0002641 |
311 | MICROTUBULE BASED PROCESS | 11 | 522 | 1.797e-05 | 0.0002689 |
312 | MESENCHYME DEVELOPMENT | 7 | 190 | 2.074e-05 | 0.0003093 |
313 | REGULATION OF CELL DIFFERENTIATION | 19 | 1492 | 2.105e-05 | 0.0003129 |
314 | CHROMATIN MODIFICATION | 11 | 539 | 2.414e-05 | 0.0003567 |
315 | SOMITE DEVELOPMENT | 5 | 78 | 2.411e-05 | 0.0003567 |
316 | REGULATION OF TRANSPORT | 21 | 1804 | 2.734e-05 | 0.0004026 |
317 | POSITIVE REGULATION OF P38MAPK CASCADE | 3 | 14 | 2.893e-05 | 0.0004246 |
318 | TUBE DEVELOPMENT | 11 | 552 | 3.003e-05 | 0.000438 |
319 | REGULATION OF CELL MORPHOGENESIS | 11 | 552 | 3.003e-05 | 0.000438 |
320 | INTERSPECIES INTERACTION BETWEEN ORGANISMS | 12 | 662 | 3.224e-05 | 0.0004674 |
321 | SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM | 12 | 662 | 3.224e-05 | 0.0004674 |
322 | MEMBRANE ORGANIZATION | 14 | 899 | 3.602e-05 | 0.0005193 |
323 | ACTIVATION OF ANAPHASE PROMOTING COMPLEX ACTIVITY | 3 | 15 | 3.605e-05 | 0.0005193 |
324 | HEART DEVELOPMENT | 10 | 466 | 3.811e-05 | 0.0005472 |
325 | CELL DEVELOPMENT | 18 | 1426 | 4.068e-05 | 0.0005824 |
326 | RESPONSE TO TRANSFORMING GROWTH FACTOR BETA | 6 | 144 | 4.187e-05 | 0.0005975 |
327 | REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 7 | 213 | 4.306e-05 | 0.0006127 |
328 | REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS | 3 | 16 | 4.422e-05 | 0.0006217 |
329 | REGULATION OF EXIT FROM MITOSIS | 3 | 16 | 4.422e-05 | 0.0006217 |
330 | NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION | 3 | 16 | 4.422e-05 | 0.0006217 |
331 | CELLULAR RESPONSE TO ANTIBIOTIC | 3 | 16 | 4.422e-05 | 0.0006217 |
332 | SEGMENTATION | 5 | 89 | 4.563e-05 | 0.0006396 |
333 | RESPONSE TO INORGANIC SUBSTANCE | 10 | 479 | 4.803e-05 | 0.0006708 |
334 | MESONEPHROS DEVELOPMENT | 5 | 90 | 4.815e-05 | 0.0006708 |
335 | REGULATION OF PROTEIN COMPLEX DISASSEMBLY | 7 | 217 | 4.845e-05 | 0.000673 |
336 | NEGATIVE REGULATION OF CELL AGING | 3 | 17 | 5.353e-05 | 0.0007369 |
337 | POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION | 3 | 17 | 5.353e-05 | 0.0007369 |
338 | REGULATION OF SISTER CHROMATID COHESION | 3 | 17 | 5.353e-05 | 0.0007369 |
339 | RESPONSE TO ANTIBIOTIC | 4 | 47 | 5.401e-05 | 0.0007392 |
340 | POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS | 4 | 47 | 5.401e-05 | 0.0007392 |
341 | MITOCHONDRION ORGANIZATION | 11 | 594 | 5.833e-05 | 0.0007959 |
342 | REGULATION OF LIPID KINASE ACTIVITY | 4 | 48 | 5.873e-05 | 0.0007967 |
343 | HOMOLOGOUS CHROMOSOME SEGREGATION | 4 | 48 | 5.873e-05 | 0.0007967 |
344 | HEAD DEVELOPMENT | 12 | 709 | 6.252e-05 | 0.0008432 |
345 | REGULATION OF PROTEIN TARGETING | 8 | 307 | 6.239e-05 | 0.0008432 |
346 | REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY | 3 | 18 | 6.403e-05 | 0.0008611 |
347 | NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS | 6 | 156 | 6.542e-05 | 0.0008773 |
348 | RESPONSE TO PROGESTERONE | 4 | 50 | 6.904e-05 | 0.0009224 |
349 | CATABOLIC PROCESS | 20 | 1773 | 6.918e-05 | 0.0009224 |
350 | HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION | 5 | 98 | 7.238e-05 | 0.0009623 |
351 | POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS | 9 | 406 | 7.436e-05 | 0.0009857 |
352 | NEGATIVE REGULATION OF GROWTH | 7 | 236 | 8.217e-05 | 0.001086 |
353 | NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 5 | 102 | 8.756e-05 | 0.001154 |
354 | RESPONSE TO TOXIC SUBSTANCE | 7 | 241 | 9.367e-05 | 0.001231 |
355 | POSITIVE REGULATION OF PROTEIN IMPORT | 5 | 104 | 9.601e-05 | 0.001258 |
356 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 19 | 1672 | 9.916e-05 | 0.001296 |
357 | CRANIAL SKELETAL SYSTEM DEVELOPMENT | 4 | 55 | 0.0001005 | 0.001311 |
358 | NEGATIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY | 6 | 170 | 0.0001052 | 0.001367 |
359 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 17 | 1395 | 0.0001065 | 0.00138 |
360 | EPITHELIAL TO MESENCHYMAL TRANSITION | 4 | 56 | 0.0001079 | 0.001395 |
361 | RESPONSE TO METAL ION | 8 | 333 | 0.0001098 | 0.001415 |
362 | NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE | 3 | 22 | 0.0001193 | 0.001529 |
363 | ENDOCARDIAL CUSHION MORPHOGENESIS | 3 | 22 | 0.0001193 | 0.001529 |
364 | REGULATION OF CELLULAR COMPONENT BIOGENESIS | 12 | 767 | 0.0001315 | 0.001681 |
365 | LYMPHOCYTE ACTIVATION | 8 | 342 | 0.0001319 | 0.001681 |
366 | POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS | 4 | 59 | 0.0001324 | 0.001683 |
367 | MULTICELLULAR ORGANISM REPRODUCTION | 12 | 768 | 0.0001331 | 0.001688 |
368 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 3 | 23 | 0.0001368 | 0.001725 |
369 | POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS | 3 | 23 | 0.0001368 | 0.001725 |
370 | EMBRYO DEVELOPMENT | 13 | 894 | 0.00014 | 0.001761 |
371 | NUCLEOTIDE EXCISION REPAIR | 5 | 113 | 0.0001421 | 0.001782 |
372 | CELLULAR RESPONSE TO HYDROGEN PEROXIDE | 4 | 61 | 0.0001508 | 0.001886 |
373 | POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 3 | 24 | 0.0001558 | 0.001933 |
374 | POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE | 3 | 24 | 0.0001558 | 0.001933 |
375 | POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 3 | 24 | 0.0001558 | 0.001933 |
376 | EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING | 10 | 554 | 0.0001594 | 0.001972 |
377 | PROTEIN LOCALIZATION TO ORGANELLE | 10 | 556 | 0.0001641 | 0.002025 |
378 | CELLULAR RESPONSE TO TOXIC SUBSTANCE | 3 | 25 | 0.0001765 | 0.002156 |
379 | REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION | 3 | 25 | 0.0001765 | 0.002156 |
380 | POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 3 | 25 | 0.0001765 | 0.002156 |
381 | EPITHELIAL CELL APOPTOTIC PROCESS | 3 | 25 | 0.0001765 | 0.002156 |
382 | CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS | 6 | 188 | 0.0001822 | 0.002208 |
383 | REGULATION OF PROTEIN ACETYLATION | 4 | 64 | 0.0001818 | 0.002208 |
384 | POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS | 4 | 64 | 0.0001818 | 0.002208 |
385 | MEIOTIC CHROMOSOME SEGREGATION | 4 | 65 | 0.000193 | 0.002321 |
386 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 12 | 799 | 0.0001923 | 0.002321 |
387 | TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY | 6 | 190 | 0.000193 | 0.002321 |
388 | CELL ACTIVATION | 10 | 568 | 0.000195 | 0.002338 |
389 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 5 | 121 | 0.0001957 | 0.002341 |
390 | NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS | 12 | 801 | 0.0001967 | 0.002347 |
391 | REGULATION OF CELLULAR SENESCENCE | 3 | 26 | 0.0001989 | 0.002349 |
392 | RESPONSE TO CORTICOSTERONE | 3 | 26 | 0.0001989 | 0.002349 |
393 | REGULATION OF P38MAPK CASCADE | 3 | 26 | 0.0001989 | 0.002349 |
394 | RESPONSE TO REACTIVE OXYGEN SPECIES | 6 | 191 | 0.0001985 | 0.002349 |
395 | NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS | 4 | 66 | 0.0002048 | 0.002406 |
396 | NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY | 4 | 66 | 0.0002048 | 0.002406 |
397 | DEVELOPMENTAL MATURATION | 6 | 193 | 0.00021 | 0.002462 |
398 | ANTERIOR POSTERIOR PATTERN SPECIFICATION | 6 | 194 | 0.000216 | 0.002525 |
399 | REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS | 4 | 67 | 0.0002171 | 0.002531 |
400 | KIDNEY EPITHELIUM DEVELOPMENT | 5 | 125 | 0.0002278 | 0.00265 |
401 | POSITIVE REGULATION OF BINDING | 5 | 127 | 0.0002452 | 0.002845 |
402 | REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR | 3 | 28 | 0.000249 | 0.002882 |
403 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 12 | 823 | 0.0002523 | 0.002913 |
404 | PROTEIN LOCALIZATION | 19 | 1805 | 0.0002686 | 0.003093 |
405 | INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY | 4 | 71 | 0.0002715 | 0.003112 |
406 | ENDODERM DEVELOPMENT | 4 | 71 | 0.0002715 | 0.003112 |
407 | POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION | 3 | 29 | 0.0002769 | 0.003165 |
408 | CELL MATURATION | 5 | 131 | 0.0002831 | 0.003229 |
409 | REGULATION OF CELL DEVELOPMENT | 12 | 836 | 0.0002911 | 0.003311 |
410 | TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR | 4 | 73 | 0.0003021 | 0.003429 |
411 | INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR | 3 | 30 | 0.0003067 | 0.003462 |
412 | ORGAN MORPHOGENESIS | 12 | 841 | 0.0003073 | 0.003462 |
413 | RESPONSE TO X RAY | 3 | 30 | 0.0003067 | 0.003462 |
414 | ESTABLISHMENT OF LOCALIZATION IN CELL | 18 | 1676 | 0.0003149 | 0.003539 |
415 | LYMPHOCYTE DIFFERENTIATION | 6 | 209 | 0.0003222 | 0.003613 |
416 | REGULATION OF PEPTIDASE ACTIVITY | 8 | 392 | 0.0003324 | 0.003718 |
417 | MACROMOLECULAR COMPLEX ASSEMBLY | 16 | 1398 | 0.0003562 | 0.003975 |
418 | NEGATIVE REGULATION OF HYDROLASE ACTIVITY | 8 | 397 | 0.0003618 | 0.004027 |
419 | NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 3 | 32 | 0.0003723 | 0.004114 |
420 | SALIVARY GLAND DEVELOPMENT | 3 | 32 | 0.0003723 | 0.004114 |
421 | ENDOCARDIAL CUSHION DEVELOPMENT | 3 | 32 | 0.0003723 | 0.004114 |
422 | PROTEIN COMPLEX BIOGENESIS | 14 | 1132 | 0.0004046 | 0.004451 |
423 | PROTEIN COMPLEX ASSEMBLY | 14 | 1132 | 0.0004046 | 0.004451 |
424 | RESPONSE TO PEPTIDE | 8 | 404 | 0.0004063 | 0.004459 |
425 | REGULATION OF CELL AGING | 3 | 33 | 0.0004082 | 0.004469 |
426 | PROTEIN TARGETING | 8 | 406 | 0.0004199 | 0.004586 |
427 | RAS PROTEIN SIGNAL TRANSDUCTION | 5 | 143 | 0.0004239 | 0.004619 |
428 | REGULATION OF PROTEIN STABILITY | 6 | 221 | 0.0004336 | 0.004703 |
429 | NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION | 6 | 221 | 0.0004336 | 0.004703 |
430 | REGULATION OF PROTEIN DEACETYLATION | 3 | 34 | 0.0004463 | 0.004796 |
431 | PROTEIN DESTABILIZATION | 3 | 34 | 0.0004463 | 0.004796 |
432 | IN UTERO EMBRYONIC DEVELOPMENT | 7 | 311 | 0.0004447 | 0.004796 |
433 | HEART VALVE DEVELOPMENT | 3 | 34 | 0.0004463 | 0.004796 |
434 | DNA GEOMETRIC CHANGE | 4 | 81 | 0.0004497 | 0.004821 |
435 | LEUKOCYTE ACTIVATION | 8 | 414 | 0.0004777 | 0.00511 |
436 | RESPONSE TO TRANSITION METAL NANOPARTICLE | 5 | 148 | 0.000496 | 0.005293 |
437 | POSITIVE REGULATION OF OSSIFICATION | 4 | 84 | 0.0005163 | 0.005497 |
438 | POSITIVE REGULATION OF PROTEIN ACETYLATION | 3 | 36 | 0.0005291 | 0.005608 |
439 | HEAD MORPHOGENESIS | 3 | 36 | 0.0005291 | 0.005608 |
440 | POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS | 4 | 86 | 0.0005644 | 0.005969 |
441 | REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION | 3 | 37 | 0.000574 | 0.006056 |
442 | TISSUE REMODELING | 4 | 87 | 0.0005897 | 0.006207 |
443 | OVULATION CYCLE PROCESS | 4 | 88 | 0.0006157 | 0.006452 |
444 | NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY | 4 | 88 | 0.0006157 | 0.006452 |
445 | POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT | 3 | 38 | 0.0006212 | 0.006466 |
446 | OOCYTE DIFFERENTIATION | 3 | 38 | 0.0006212 | 0.006466 |
447 | REGULATION OF MULTICELLULAR ORGANISMAL METABOLIC PROCESS | 3 | 38 | 0.0006212 | 0.006466 |
448 | CELLULAR RESPONSE TO INORGANIC SUBSTANCE | 5 | 156 | 0.0006301 | 0.006544 |
449 | POSITIVE REGULATION OF GROWTH | 6 | 238 | 0.0006406 | 0.006638 |
450 | B CELL DIFFERENTIATION | 4 | 89 | 0.0006425 | 0.006643 |
451 | REGULATION OF DEPHOSPHORYLATION | 5 | 158 | 0.0006675 | 0.006886 |
452 | CELLULAR RESPONSE TO NUTRIENT | 3 | 39 | 0.0006708 | 0.00689 |
453 | SPLEEN DEVELOPMENT | 3 | 39 | 0.0006708 | 0.00689 |
454 | REGULATION OF ORGAN MORPHOGENESIS | 6 | 242 | 0.0006989 | 0.007163 |
455 | POSITIVE REGULATION OF CELL MATRIX ADHESION | 3 | 40 | 0.0007229 | 0.00736 |
456 | RESPONSE TO EXTRACELLULAR STIMULUS | 8 | 441 | 0.0007224 | 0.00736 |
457 | RESPONSE TO CADMIUM ION | 3 | 40 | 0.0007229 | 0.00736 |
458 | NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION | 3 | 41 | 0.0007775 | 0.007882 |
459 | ANDROGEN RECEPTOR SIGNALING PATHWAY | 3 | 41 | 0.0007775 | 0.007882 |
460 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 17 | 1656 | 0.0007938 | 0.008029 |
461 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 15 | 1360 | 0.0008172 | 0.008249 |
462 | COVALENT CHROMATIN MODIFICATION | 7 | 345 | 0.0008209 | 0.008267 |
463 | REGULATION OF CYTOKINE PRODUCTION | 9 | 563 | 0.0008257 | 0.008298 |
464 | REGULATION OF NEURON DEATH | 6 | 252 | 0.0008627 | 0.008651 |
465 | RESPONSE TO CARBOHYDRATE | 5 | 168 | 0.00088 | 0.008805 |
466 | BETA CATENIN TCF COMPLEX ASSEMBLY | 3 | 43 | 0.0008944 | 0.008931 |
467 | LEUKOCYTE CELL CELL ADHESION | 6 | 255 | 0.0009172 | 0.009138 |
468 | RESPONSE TO VITAMIN | 4 | 98 | 0.0009225 | 0.009156 |
469 | RESPONSE TO OXIDATIVE STRESS | 7 | 352 | 0.0009229 | 0.009156 |
470 | BODY MORPHOGENESIS | 3 | 44 | 0.0009568 | 0.009465 |
471 | EXTRINSIC APOPTOTIC SIGNALING PATHWAY | 4 | 99 | 0.0009581 | 0.009465 |
472 | REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION | 4 | 100 | 0.0009947 | 0.009785 |
473 | PEPTIDYL TYROSINE DEPHOSPHORYLATION | 4 | 100 | 0.0009947 | 0.009785 |
474 | REGULATION OF MITOTIC SPINDLE CHECKPOINT | 2 | 11 | 0.001026 | 0.009987 |
475 | REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY | 2 | 11 | 0.001026 | 0.009987 |
476 | SUBSTANTIA NIGRA DEVELOPMENT | 3 | 45 | 0.001022 | 0.009987 |
477 | EXOCRINE SYSTEM DEVELOPMENT | 3 | 45 | 0.001022 | 0.009987 |
478 | REGULATION OF MITOTIC CELL CYCLE SPINDLE ASSEMBLY CHECKPOINT | 2 | 11 | 0.001026 | 0.009987 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | ENZYME BINDING | 36 | 1737 | 3.082e-16 | 2.863e-13 |
2 | KINASE BINDING | 23 | 606 | 1.081e-15 | 5.022e-13 |
3 | PROTEIN KINASE ACTIVITY | 22 | 640 | 3.81e-14 | 1.18e-11 |
4 | CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY | 8 | 28 | 2.934e-13 | 6.815e-11 |
5 | PROTEIN SERINE THREONINE KINASE ACTIVITY | 18 | 445 | 7.345e-13 | 1.365e-10 |
6 | KINASE ACTIVITY | 23 | 842 | 1.1e-12 | 1.46e-10 |
7 | TRANSCRIPTION FACTOR BINDING | 19 | 524 | 1.072e-12 | 1.46e-10 |
8 | TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 23 | 992 | 3.074e-11 | 3.57e-09 |
9 | KINASE REGULATOR ACTIVITY | 11 | 186 | 5.748e-10 | 5.933e-08 |
10 | PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 6 | 30 | 3.329e-09 | 2.812e-07 |
11 | PROTEIN COMPLEX BINDING | 20 | 935 | 3.052e-09 | 2.812e-07 |
12 | MACROMOLECULAR COMPLEX BINDING | 24 | 1399 | 4.695e-09 | 3.635e-07 |
13 | CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY | 6 | 34 | 7.435e-09 | 5.314e-07 |
14 | ADENYL NUCLEOTIDE BINDING | 23 | 1514 | 1.008e-07 | 6.691e-06 |
15 | CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY | 4 | 12 | 1.686e-07 | 1.044e-05 |
16 | RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING | 7 | 104 | 3.767e-07 | 2.188e-05 |
17 | STEROID HORMONE RECEPTOR BINDING | 6 | 81 | 1.521e-06 | 8.312e-05 |
18 | KINASE INHIBITOR ACTIVITY | 6 | 89 | 2.648e-06 | 0.0001238 |
19 | TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING | 5 | 50 | 2.665e-06 | 0.0001238 |
20 | UBIQUITIN LIKE PROTEIN LIGASE BINDING | 9 | 264 | 2.444e-06 | 0.0001238 |
21 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 18 | 1199 | 3.877e-06 | 0.0001637 |
22 | RIBONUCLEOTIDE BINDING | 23 | 1860 | 3.713e-06 | 0.0001637 |
23 | ACTIVATING TRANSCRIPTION FACTOR BINDING | 5 | 57 | 5.141e-06 | 0.0002076 |
24 | PROTEIN HETERODIMERIZATION ACTIVITY | 11 | 468 | 6.475e-06 | 0.0002506 |
25 | P53 BINDING | 5 | 67 | 1.146e-05 | 0.0004257 |
26 | SMAD BINDING | 5 | 72 | 1.631e-05 | 0.0005828 |
27 | ENZYME REGULATOR ACTIVITY | 15 | 959 | 1.739e-05 | 0.0005929 |
28 | RNA POLYMERASE II ACTIVATING TRANSCRIPTION FACTOR BINDING | 4 | 36 | 1.851e-05 | 0.0005929 |
29 | PROTEIN DOMAIN SPECIFIC BINDING | 12 | 624 | 1.805e-05 | 0.0005929 |
30 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 12 | 629 | 1.953e-05 | 0.0006048 |
31 | CHROMATIN BINDING | 10 | 435 | 2.124e-05 | 0.0006364 |
32 | ANDROGEN RECEPTOR BINDING | 4 | 39 | 2.559e-05 | 0.000722 |
33 | DNA DEPENDENT ATPASE ACTIVITY | 5 | 79 | 2.565e-05 | 0.000722 |
34 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING | 3 | 15 | 3.605e-05 | 0.0009849 |
35 | TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING | 11 | 588 | 5.324e-05 | 0.001413 |
36 | CORE PROMOTER BINDING | 6 | 152 | 5.663e-05 | 0.001461 |
37 | RECEPTOR BINDING | 18 | 1476 | 6.374e-05 | 0.0016 |
38 | CYCLIN BINDING | 3 | 19 | 7.58e-05 | 0.001717 |
39 | TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING | 8 | 315 | 7.467e-05 | 0.001717 |
40 | MOLECULAR FUNCTION REGULATOR | 17 | 1353 | 7.319e-05 | 0.001717 |
41 | HISTONE KINASE ACTIVITY | 3 | 19 | 7.58e-05 | 0.001717 |
42 | PHOSPHATASE BINDING | 6 | 162 | 8.064e-05 | 0.001784 |
43 | DNA HELICASE ACTIVITY | 4 | 53 | 8.691e-05 | 0.001878 |
44 | HORMONE RECEPTOR BINDING | 6 | 168 | 9.855e-05 | 0.002081 |
45 | R SMAD BINDING | 3 | 23 | 0.0001368 | 0.002824 |
46 | PHOSPHOPROTEIN BINDING | 4 | 60 | 0.0001414 | 0.002855 |
47 | PROTEIN C TERMINUS BINDING | 6 | 186 | 0.0001719 | 0.003327 |
48 | DAMAGED DNA BINDING | 4 | 63 | 0.000171 | 0.003327 |
49 | REGULATORY REGION NUCLEIC ACID BINDING | 12 | 818 | 0.0002386 | 0.004524 |
50 | BHLH TRANSCRIPTION FACTOR BINDING | 3 | 28 | 0.000249 | 0.004627 |
51 | ATP DEPENDENT DNA HELICASE ACTIVITY | 3 | 34 | 0.0004463 | 0.008129 |
52 | PROTEIN DIMERIZATION ACTIVITY | 14 | 1149 | 0.0004697 | 0.008392 |
53 | BETA CATENIN BINDING | 4 | 84 | 0.0005163 | 0.008892 |
54 | DOUBLE STRANDED DNA BINDING | 11 | 764 | 0.0005169 | 0.008892 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CHROMOSOME | 30 | 880 | 3.235e-19 | 1.889e-16 |
2 | CHROMOSOMAL REGION | 20 | 330 | 1.401e-17 | 4.092e-15 |
3 | NUCLEAR CHROMOSOME | 23 | 523 | 4.449e-17 | 6.495e-15 |
4 | TRANSCRIPTION FACTOR COMPLEX | 19 | 298 | 3.884e-17 | 6.495e-15 |
5 | TRANSFERASE COMPLEX | 24 | 703 | 2.433e-15 | 2.842e-13 |
6 | CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX | 9 | 31 | 7.562e-15 | 7.36e-13 |
7 | ANAPHASE PROMOTING COMPLEX | 8 | 22 | 3.084e-14 | 2.573e-12 |
8 | MICROTUBULE CYTOSKELETON | 26 | 1068 | 3.7e-13 | 2.701e-11 |
9 | CHROMATIN | 18 | 441 | 6.308e-13 | 4.093e-11 |
10 | SPINDLE | 15 | 289 | 2.144e-12 | 1.252e-10 |
11 | PROTEIN KINASE COMPLEX | 10 | 90 | 6.9e-12 | 3.663e-10 |
12 | CATALYTIC COMPLEX | 24 | 1038 | 1.094e-11 | 4.916e-10 |
13 | NUCLEAR UBIQUITIN LIGASE COMPLEX | 8 | 42 | 1.06e-11 | 4.916e-10 |
14 | CULLIN RING UBIQUITIN LIGASE COMPLEX | 11 | 150 | 5.691e-11 | 2.374e-09 |
15 | CHROMOSOME TELOMERIC REGION | 10 | 162 | 2.412e-09 | 9.392e-08 |
16 | CENTROSOME | 15 | 487 | 3.148e-09 | 1.149e-07 |
17 | CONDENSED NUCLEAR CHROMOSOME | 8 | 85 | 3.708e-09 | 1.274e-07 |
18 | CHROMOSOME CENTROMERIC REGION | 10 | 174 | 4.818e-09 | 1.563e-07 |
19 | TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS | 11 | 237 | 7.363e-09 | 2.263e-07 |
20 | CYTOSKELETON | 28 | 1967 | 1.068e-08 | 3.119e-07 |
21 | MICROTUBULE ORGANIZING CENTER | 16 | 623 | 1.173e-08 | 3.263e-07 |
22 | CONDENSED CHROMOSOME | 10 | 195 | 1.438e-08 | 3.817e-07 |
23 | UBIQUITIN LIGASE COMPLEX | 11 | 262 | 2.077e-08 | 5.274e-07 |
24 | CYTOSKELETAL PART | 23 | 1436 | 3.835e-08 | 9.331e-07 |
25 | SPINDLE POLE | 8 | 126 | 8.362e-08 | 1.953e-06 |
26 | MCM COMPLEX | 4 | 11 | 1.128e-07 | 2.533e-06 |
27 | NUCLEAR CHROMOSOME TELOMERIC REGION | 8 | 132 | 1.2e-07 | 2.596e-06 |
28 | CONDENSED CHROMOSOME OUTER KINETOCHORE | 4 | 12 | 1.686e-07 | 3.516e-06 |
29 | RNA POLYMERASE II TRANSCRIPTION FACTOR COMPLEX | 7 | 101 | 3.083e-07 | 6.208e-06 |
30 | CONDENSED NUCLEAR CHROMOSOME CENTROMERIC REGION | 4 | 18 | 1.021e-06 | 1.988e-05 |
31 | NUCLEAR TRANSCRIPTION FACTOR COMPLEX | 7 | 127 | 1.461e-06 | 2.752e-05 |
32 | CONDENSED CHROMOSOME CENTROMERIC REGION | 6 | 102 | 5.862e-06 | 0.000107 |
33 | COHESIN COMPLEX | 3 | 11 | 1.324e-05 | 0.0002343 |
34 | KINETOCHORE | 6 | 120 | 1.493e-05 | 0.0002564 |
35 | CYTOPLASMIC VESICLE PART | 11 | 601 | 6.478e-05 | 0.001081 |
36 | NUCLEOLUS | 13 | 848 | 8.263e-05 | 0.00134 |
37 | CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX | 3 | 22 | 0.0001193 | 0.001883 |
38 | SPINDLE MIDZONE | 3 | 27 | 0.000223 | 0.003428 |
39 | NUCLEAR CHROMATIN | 7 | 291 | 0.0002983 | 0.004466 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04110_Cell_cycle | 88 | 128 | 1.85e-211 | 3.33e-209 | |
2 | hsa04114_Oocyte_meiosis | 26 | 114 | 2.331e-38 | 2.098e-36 | |
3 | hsa04115_p53_signaling_pathway | 19 | 69 | 8.182e-30 | 4.909e-28 | |
4 | hsa04350_TGF.beta_signaling_pathway | 16 | 85 | 2.893e-22 | 1.302e-20 | |
5 | hsa04914_Progesterone.mediated_oocyte_maturation | 16 | 87 | 4.326e-22 | 1.557e-20 | |
6 | hsa04390_Hippo_signaling_pathway | 17 | 154 | 1.83e-19 | 5.489e-18 | |
7 | hsa04151_PI3K_AKT_signaling_pathway | 20 | 351 | 4.656e-17 | 1.197e-15 | |
8 | hsa04310_Wnt_signaling_pathway | 12 | 151 | 2.766e-12 | 6.224e-11 | |
9 | hsa04120_Ubiquitin_mediated_proteolysis | 10 | 139 | 5.397e-10 | 1.079e-08 | |
10 | hsa04722_Neurotrophin_signaling_pathway | 9 | 127 | 4.721e-09 | 8.498e-08 | |
11 | hsa03030_DNA_replication | 5 | 36 | 4.977e-07 | 8.145e-06 | |
12 | hsa04010_MAPK_signaling_pathway | 9 | 268 | 2.764e-06 | 4.146e-05 | |
13 | hsa04520_Adherens_junction | 5 | 73 | 1.745e-05 | 0.0002416 | |
14 | hsa04012_ErbB_signaling_pathway | 5 | 87 | 4.09e-05 | 0.0005259 | |
15 | hsa04630_Jak.STAT_signaling_pathway | 6 | 155 | 6.313e-05 | 0.0007575 | |
16 | hsa04144_Endocytosis | 6 | 203 | 0.0002757 | 0.003101 | |
17 | hsa03420_Nucleotide_excision_repair | 3 | 45 | 0.001022 | 0.01082 | |
18 | hsa04916_Melanogenesis | 3 | 101 | 0.01006 | 0.1006 | |
19 | hsa04510_Focal_adhesion | 4 | 200 | 0.01178 | 0.1116 | |
20 | hsa04330_Notch_signaling_pathway | 2 | 47 | 0.0182 | 0.1638 | |
21 | hsa04720_Long.term_potentiation | 2 | 70 | 0.03811 | 0.3266 | |
22 | hsa04210_Apoptosis | 2 | 89 | 0.0586 | 0.4687 | |
23 | hsa04380_Osteoclast_differentiation | 2 | 128 | 0.1092 | 0.7467 | |
24 | hsa04360_Axon_guidance | 2 | 130 | 0.112 | 0.7467 |
Num | lncRNA | miRNAs | miRNAs count | Gene | Sponge regulatory network | lncRNA log2FC | lncRNA pvalue | Gene log2FC | Gene pvalue | lncRNA-gene Pearson correlation |
---|---|---|---|---|---|---|---|---|---|---|
1 | LINC00941 | hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-335-5p;hsa-miR-340-5p;hsa-miR-374a-3p;hsa-miR-378a-3p;hsa-miR-497-5p | 22 | CDK6 | Sponge network | 4.292 | 0 | 0.944 | 0 | 0.658 |
2 | AC007879.5 | hsa-miR-101-3p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-34a-5p;hsa-miR-502-3p | 12 | CDK6 | Sponge network | 2.671 | 0 | 0.944 | 0 | 0.595 |
3 | AC007879.7 | hsa-miR-101-3p;hsa-miR-140-3p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-340-5p | 18 | CDK6 | Sponge network | 2.7 | 0 | 0.944 | 0 | 0.587 |
4 | RP11-221N13.3 | hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-142-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-9-5p | 15 | CDK6 | Sponge network | 5.876 | 0 | 0.944 | 0 | 0.56 |
5 | RP11-150O12.1 |
hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-16-5p;hsa-miR-195-5p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-335-5p | 17 | CDK6 | Sponge network | 1.523 | 0 | 0.944 | 0 | 0.534 |
6 | RP11-30P6.6 |
hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-141-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-374a-5p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-660-5p | 28 | CDK6 | Sponge network | 2.847 | 0 | 0.944 | 0 | 0.53 |
7 | CTD-2547L24.4 | hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-378a-3p | 13 | CDK6 | Sponge network | 1.587 | 0 | 0.944 | 0 | 0.508 |
8 | LINC00707 |
hsa-miR-106a-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-340-5p;hsa-miR-34a-5p;hsa-miR-374a-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-497-5p;hsa-miR-664a-3p | 31 | CDK6 | Sponge network | 2.018 | 1.0E-5 | 0.944 | 0 | 0.503 |
9 | AC011738.4 |
hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-16-5p;hsa-miR-191-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-320a;hsa-miR-34a-5p;hsa-miR-374a-3p;hsa-miR-378a-3p;hsa-miR-497-5p;hsa-miR-664a-3p;hsa-miR-7-1-3p;hsa-miR-9-5p | 25 | CDK6 | Sponge network | 3.153 | 0 | 0.944 | 0 | 0.489 |
10 | RP5-1198O20.4 |
hsa-miR-125a-5p;hsa-miR-140-3p;hsa-miR-217;hsa-miR-28-5p;hsa-miR-30a-5p;hsa-miR-328-3p;hsa-miR-335-3p;hsa-miR-374a-3p;hsa-miR-582-3p;hsa-miR-664a-3p | 10 | YWHAZ | Sponge network | 0.114 | 0.54508 | 0.345 | 0.0016 | 0.481 |
11 | RP11-890B15.2 | hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-34a-5p;hsa-miR-374a-3p;hsa-miR-497-5p;hsa-miR-9-5p | 21 | CDK6 | Sponge network | 4.029 | 0 | 0.944 | 0 | 0.474 |
12 | RP5-884M6.1 | hsa-miR-101-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-378a-3p | 18 | CDK6 | Sponge network | 6.548 | 0 | 0.944 | 0 | 0.471 |
13 | RP13-463N16.6 | hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p | 11 | CDK6 | Sponge network | 3.312 | 0 | 0.944 | 0 | 0.463 |
14 | MIR31HG | hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-23b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-34a-5p | 11 | CDK6 | Sponge network | 0.768 | 0.15574 | 0.944 | 0 | 0.463 |
15 | RP11-462L8.1 | hsa-miR-101-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-34a-5p;hsa-miR-9-5p | 13 | CDK6 | Sponge network | 4.262 | 0 | 0.944 | 0 | 0.453 |
16 | RP11-417E7.1 | hsa-miR-106a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30a-5p | 11 | CDK6 | Sponge network | 3.987 | 0 | 0.944 | 0 | 0.449 |
17 | CTD-2066L21.3 | hsa-miR-101-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-200b-3p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-335-5p;hsa-miR-9-5p | 19 | CDK6 | Sponge network | 5.449 | 0 | 0.944 | 0 | 0.447 |
18 | RP1-193H18.2 | hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-21-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-450b-5p;hsa-miR-576-5p | 10 | SMAD4 | Sponge network | -1.539 | 0 | -0.43 | 0 | 0.443 |
19 | FAM83A-AS1 |
hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-let-7i-5p;hsa-miR-101-3p;hsa-miR-106b-5p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-491-5p | 11 | CDKN1A | Sponge network | 1.064 | 0.00307 | 0.128 | 0.35863 | 0.44 |
20 | LINC00518 | hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p | 13 | CDK6 | Sponge network | 2.747 | 4.0E-5 | 0.944 | 0 | 0.436 |
21 | LINC00707 |
hsa-miR-195-3p;hsa-miR-217;hsa-miR-28-5p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-328-3p;hsa-miR-335-3p;hsa-miR-374a-3p;hsa-miR-378a-3p;hsa-miR-664a-3p | 13 | YWHAZ | Sponge network | 2.018 | 1.0E-5 | 0.345 | 0.0016 | 0.436 |
22 | RP11-445F12.1 | hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-340-5p;hsa-miR-497-5p | 15 | CDK6 | Sponge network | 7.107 | 0 | 0.944 | 0 | 0.435 |
23 | RP11-218E20.3 |
hsa-miR-101-3p;hsa-miR-140-3p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-32-5p;hsa-miR-374a-5p;hsa-miR-374b-5p;hsa-miR-497-5p | 24 | CDK6 | Sponge network | 4.613 | 0 | 0.944 | 0 | 0.434 |
24 | RP11-42I10.1 | hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-142-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p | 15 | CDK6 | Sponge network | 2.1 | 0 | 0.944 | 0 | 0.432 |
25 | LINC00704 | hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30e-3p | 12 | CDK6 | Sponge network | 2.465 | 0 | 0.944 | 0 | 0.43 |
26 | MAGI2-AS3 |
hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-149-5p;hsa-miR-200a-3p;hsa-miR-29b-3p;hsa-miR-33a-3p;hsa-miR-362-5p;hsa-miR-429;hsa-miR-454-3p;hsa-miR-500a-5p;hsa-miR-500b-5p;hsa-miR-589-3p;hsa-miR-944 | 13 | TGFB2 | Sponge network | -0.939 | 4.0E-5 | 0.078 | 0.72302 | 0.43 |
27 | LINC00460 | hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-429;hsa-miR-497-5p | 16 | CDK6 | Sponge network | 7.222 | 0 | 0.944 | 0 | 0.425 |
28 | LINC00958 | hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-340-5p;hsa-miR-374a-3p;hsa-miR-497-5p | 11 | CDK6 | Sponge network | 1.836 | 0 | 0.944 | 0 | 0.422 |
29 | XXyac-YX65C7_A.3 | hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-5p;hsa-miR-30e-5p | 17 | CDK6 | Sponge network | 6.112 | 0 | 0.944 | 0 | 0.418 |
30 | KB-1732A1.1 |
hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-30b-3p;hsa-miR-429;hsa-miR-491-5p | 12 | CDKN1A | Sponge network | 1.697 | 0 | 0.128 | 0.35863 | 0.417 |
31 | CTD-2587H24.5 | hsa-miR-101-3p;hsa-miR-140-3p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-497-5p;hsa-miR-582-5p | 20 | CDK6 | Sponge network | 7.138 | 0 | 0.944 | 0 | 0.417 |
32 | KTN1-AS1 | hsa-miR-101-3p;hsa-miR-140-3p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-34a-5p;hsa-miR-378a-3p | 16 | CDK6 | Sponge network | 1.107 | 0 | 0.944 | 0 | 0.412 |
33 | RP11-1020M18.10 | hsa-miR-106a-5p;hsa-miR-146a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-497-5p;hsa-miR-582-5p | 10 | CDK6 | Sponge network | 6.911 | 0 | 0.944 | 0 | 0.404 |
34 | TTLL11-IT1 | hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-200b-3p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p | 11 | CDK6 | Sponge network | 5.5 | 0 | 0.944 | 0 | 0.397 |
35 | AC108142.1 | hsa-miR-101-3p;hsa-miR-141-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29c-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-34a-5p;hsa-miR-362-5p;hsa-miR-374a-5p;hsa-miR-374b-5p;hsa-miR-429;hsa-miR-7-1-3p | 24 | CDK6 | Sponge network | 2.31 | 0 | 0.944 | 0 | 0.396 |
36 | LINC00702 |
hsa-miR-141-3p;hsa-miR-142-3p;hsa-miR-149-5p;hsa-miR-200a-3p;hsa-miR-33a-3p;hsa-miR-454-3p;hsa-miR-500a-5p;hsa-miR-500b-5p;hsa-miR-589-3p;hsa-miR-590-5p | 10 | TGFB2 | Sponge network | -0.573 | 0.0699 | 0.078 | 0.72302 | 0.396 |
37 | KB-1732A1.1 |
hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-378a-3p;hsa-miR-429;hsa-miR-497-5p | 23 | CDK6 | Sponge network | 1.697 | 0 | 0.944 | 0 | 0.394 |
38 | RP11-557H15.3 |
hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-26a-5p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-335-3p;hsa-miR-340-5p;hsa-miR-374b-5p;hsa-miR-378a-3p | 15 | CDK6 | Sponge network | 1.673 | 8.0E-5 | 0.944 | 0 | 0.393 |
39 | RP11-366H4.1 | hsa-miR-101-3p;hsa-miR-148a-3p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-30a-3p;hsa-miR-340-5p;hsa-miR-374a-5p;hsa-miR-497-5p | 12 | CDK6 | Sponge network | 4.872 | 0 | 0.944 | 0 | 0.39 |
40 | RP11-554I8.2 |
hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29c-3p;hsa-miR-378a-3p | 14 | CDK6 | Sponge network | 0.342 | 0.50007 | 0.944 | 0 | 0.389 |
41 | CTD-2555C10.3 |
hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-664a-3p | 14 | CDK6 | Sponge network | 1.037 | 0.0004 | 0.944 | 0 | 0.389 |
42 | RP11-346D19.1 | hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30a-3p;hsa-miR-340-5p | 11 | CDK6 | Sponge network | 6.549 | 0 | 0.944 | 0 | 0.38 |
43 | CTD-2357A8.3 | hsa-miR-101-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-335-5p;hsa-miR-34a-5p | 11 | CDK6 | Sponge network | 7.162 | 0 | 0.944 | 0 | 0.38 |
44 | APCDD1L-AS1 |
hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-141-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-335-3p;hsa-miR-378a-3p;hsa-miR-497-5p;hsa-miR-7-1-3p;hsa-miR-9-5p | 24 | CDK6 | Sponge network | 2.077 | 0 | 0.944 | 0 | 0.379 |
45 | CTD-2555C10.3 |
hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-let-7i-5p;hsa-miR-106b-5p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-30b-3p;hsa-miR-491-5p | 10 | CDKN1A | Sponge network | 1.037 | 0.0004 | 0.128 | 0.35863 | 0.379 |
46 | MAGI2-AS3 |
hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-21-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-454-3p;hsa-miR-576-5p | 10 | SMAD4 | Sponge network | -0.939 | 4.0E-5 | -0.43 | 0 | 0.379 |
47 | NOP14-AS1 |
hsa-miR-101-3p;hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-335-5p;hsa-miR-340-5p;hsa-miR-34a-5p;hsa-miR-374a-3p;hsa-miR-378a-3p;hsa-miR-497-5p;hsa-miR-502-3p | 25 | CDK6 | Sponge network | 0.939 | 0 | 0.944 | 0 | 0.374 |
48 | AC006262.4 |
hsa-miR-106a-5p;hsa-miR-142-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-16-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-497-5p;hsa-miR-582-5p | 15 | CDK6 | Sponge network | 1.721 | 0.01526 | 0.944 | 0 | 0.373 |
49 | RP11-497E19.1 |
hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-141-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29c-3p;hsa-miR-335-3p;hsa-miR-664a-3p;hsa-miR-7-1-3p | 19 | CDK6 | Sponge network | 2.366 | 0.00063 | 0.944 | 0 | 0.373 |
50 | RP11-150O12.1 |
hsa-let-7c-5p;hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-30b-3p;hsa-miR-335-5p;hsa-miR-423-5p | 11 | CDKN1A | Sponge network | 1.523 | 0 | 0.128 | 0.35863 | 0.369 |
51 | RP11-58E21.3 |
hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-148a-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-362-5p | 14 | CDK6 | Sponge network | 0.445 | 0.04375 | 0.944 | 0 | 0.365 |
52 | RP11-58E21.3 |
hsa-let-7c-5p;hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-30b-3p;hsa-miR-335-5p;hsa-miR-345-5p;hsa-miR-491-5p;hsa-miR-93-5p | 11 | CDKN1A | Sponge network | 0.445 | 0.04375 | 0.128 | 0.35863 | 0.36 |
53 | AC005682.5 | hsa-miR-101-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-3p;hsa-miR-340-5p | 12 | CDK6 | Sponge network | 1.074 | 0 | 0.944 | 0 | 0.358 |
54 | LINC00973 | hsa-miR-101-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-200b-3p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-335-5p | 10 | CDK6 | Sponge network | 5.015 | 0 | 0.944 | 0 | 0.357 |
55 | VPS9D1-AS1 | hsa-miR-101-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-378a-3p;hsa-miR-497-5p | 10 | CDK6 | Sponge network | 1.07 | 1.0E-5 | 0.944 | 0 | 0.353 |
56 | RP11-145A3.1 | hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p | 14 | CDK6 | Sponge network | 2.565 | 0 | 0.944 | 0 | 0.353 |
57 | RP11-30P6.6 |
hsa-miR-140-3p;hsa-miR-148a-3p;hsa-miR-181c-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-5p;hsa-miR-30e-5p | 10 | YWHAG | Sponge network | 2.847 | 0 | 0.33 | 0.00014 | 0.353 |
58 | BHLHE40-AS1 | hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-450b-5p;hsa-miR-576-5p;hsa-miR-590-5p | 10 | SMAD4 | Sponge network | -0.932 | 0 | -0.43 | 0 | 0.353 |
59 | RP11-227H15.4 |
hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-16-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-5p;hsa-miR-34a-5p;hsa-miR-374a-3p;hsa-miR-497-5p | 22 | CDK6 | Sponge network | 4.405 | 0 | 0.944 | 0 | 0.352 |
60 | LUCAT1 | hsa-miR-101-3p;hsa-miR-148a-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-335-5p;hsa-miR-429;hsa-miR-660-5p | 16 | CDK6 | Sponge network | 1.475 | 0 | 0.944 | 0 | 0.351 |
61 | MIR22HG | hsa-let-7a-5p;hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-28-5p;hsa-miR-345-5p;hsa-miR-582-5p;hsa-miR-93-5p | 10 | CDKN1A | Sponge network | -0.601 | 4.0E-5 | 0.128 | 0.35863 | 0.348 |
62 | FAM83A-AS1 |
hsa-miR-101-3p;hsa-miR-148a-3p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-378a-3p | 14 | CDK6 | Sponge network | 1.064 | 0.00307 | 0.944 | 0 | 0.343 |
63 | RP11-479G22.8 | hsa-miR-101-3p;hsa-miR-140-3p;hsa-miR-141-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-429 | 17 | CDK6 | Sponge network | 0.955 | 0 | 0.944 | 0 | 0.342 |
64 | LINC00707 |
hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-30b-3p;hsa-miR-335-5p;hsa-miR-345-5p;hsa-miR-363-3p;hsa-miR-429;hsa-miR-491-5p | 12 | CDKN1A | Sponge network | 2.018 | 1.0E-5 | 0.128 | 0.35863 | 0.338 |
65 | RP11-285E9.6 | hsa-miR-101-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-497-5p | 10 | CDK6 | Sponge network | 1.44 | 1.0E-5 | 0.944 | 0 | 0.336 |
66 | RP11-11N5.1 | hsa-miR-140-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-335-5p | 10 | CDK6 | Sponge network | 5.005 | 0 | 0.944 | 0 | 0.328 |
67 | RP11-557H15.3 |
hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-30b-3p | 10 | CDKN1A | Sponge network | 1.673 | 8.0E-5 | 0.128 | 0.35863 | 0.328 |
68 | RP11-524H19.2 | hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-191-5p;hsa-miR-218-5p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-340-5p;hsa-miR-374a-3p | 10 | CDK6 | Sponge network | 0.759 | 0.01839 | 0.944 | 0 | 0.326 |
69 | RP11-78C3.1 | hsa-miR-101-3p;hsa-miR-140-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-217;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p | 10 | CDK6 | Sponge network | 5.978 | 0 | 0.944 | 0 | 0.324 |
70 | RP11-398K22.12 | hsa-miR-101-3p;hsa-miR-140-3p;hsa-miR-195-5p;hsa-miR-30a-5p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-335-5p;hsa-miR-340-5p;hsa-miR-378a-3p;hsa-miR-664a-3p | 11 | CDK6 | Sponge network | 1.036 | 0 | 0.944 | 0 | 0.324 |
71 | RP11-25I15.3 | hsa-miR-106a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p | 11 | CDK6 | Sponge network | 5.655 | 0 | 0.944 | 0 | 0.323 |
72 | LINC00911 | hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-491-5p | 10 | CDKN1A | Sponge network | 4.956 | 0 | 0.128 | 0.35863 | 0.323 |
73 | NOP14-AS1 |
hsa-miR-140-3p;hsa-miR-195-3p;hsa-miR-217;hsa-miR-28-5p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-374a-3p;hsa-miR-378a-3p | 10 | YWHAZ | Sponge network | 0.939 | 0 | 0.345 | 0.0016 | 0.321 |
74 | AF127936.7 |
hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-141-3p;hsa-miR-148a-5p;hsa-miR-16-1-3p;hsa-miR-16-5p;hsa-miR-191-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-320a;hsa-miR-362-5p;hsa-miR-374a-5p;hsa-miR-378a-3p;hsa-miR-660-5p;hsa-miR-7-1-3p | 22 | CDK6 | Sponge network | 0.453 | 0.00811 | 0.944 | 0 | 0.315 |
75 | CTD-2171N6.1 | hsa-miR-101-3p;hsa-miR-140-3p;hsa-miR-141-3p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29b-3p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30b-5p;hsa-miR-30c-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-30e-3p;hsa-miR-30e-5p;hsa-miR-34a-5p;hsa-miR-497-5p;hsa-miR-502-3p;hsa-miR-582-5p | 28 | CDK6 | Sponge network | 5.89 | 0 | 0.944 | 0 | 0.31 |
76 | LINC00520 | hsa-miR-101-3p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-217;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-335-3p;hsa-miR-374a-5p;hsa-miR-374b-5p;hsa-miR-497-5p | 15 | CDK6 | Sponge network | 3.383 | 0 | 0.944 | 0 | 0.303 |
77 | AC093627.10 | hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-21-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-450b-5p;hsa-miR-454-3p | 10 | SMAD4 | Sponge network | -0.893 | 0.00123 | -0.43 | 0 | 0.301 |
78 | RP11-863P13.3 | hsa-miR-140-3p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-502-3p | 12 | CDK6 | Sponge network | 4.189 | 0 | 0.944 | 0 | 0.3 |
79 | RP4-794H19.1 |
hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-30b-3p;hsa-miR-345-5p;hsa-miR-363-3p;hsa-miR-491-5p | 11 | CDKN1A | Sponge network | 1.019 | 8.0E-5 | 0.128 | 0.35863 | 0.298 |
80 | MAGI2-AS3 |
hsa-miR-182-5p;hsa-miR-186-5p;hsa-miR-193b-3p;hsa-miR-20a-5p;hsa-miR-2355-3p;hsa-miR-25-3p;hsa-miR-26b-5p;hsa-miR-29b-1-5p;hsa-miR-30c-5p;hsa-miR-339-5p;hsa-miR-342-3p;hsa-miR-582-3p;hsa-miR-590-3p;hsa-miR-92a-3p | 14 | EP300 | Sponge network | -0.939 | 4.0E-5 | -0.038 | 0.77828 | 0.297 |
81 | RP11-297P16.3 | hsa-miR-101-3p;hsa-miR-142-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-5p;hsa-miR-30e-5p;hsa-miR-340-5p | 14 | CDK6 | Sponge network | 6.381 | 0 | 0.944 | 0 | 0.288 |
82 | CTA-392E5.1 | hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-195-5p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-335-3p;hsa-miR-335-5p;hsa-miR-378a-3p | 16 | CDK6 | Sponge network | 5.137 | 0 | 0.944 | 0 | 0.285 |
83 | RP11-879F14.2 | hsa-miR-101-3p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-3p;hsa-miR-378a-3p | 14 | CDK6 | Sponge network | 1.149 | 9.0E-5 | 0.944 | 0 | 0.274 |
84 | RP11-244O19.1 | hsa-miR-141-3p;hsa-miR-148a-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-218-5p;hsa-miR-23b-3p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-30d-3p;hsa-miR-30d-5p;hsa-miR-34a-5p;hsa-miR-378a-3p | 12 | CDK6 | Sponge network | 0.52 | 0.05156 | 0.944 | 0 | 0.274 |
85 | CTD-2354A18.1 | hsa-miR-101-3p;hsa-miR-140-3p;hsa-miR-195-5p;hsa-miR-217;hsa-miR-26a-5p;hsa-miR-29c-3p;hsa-miR-30a-3p;hsa-miR-30a-5p;hsa-miR-30e-3p;hsa-miR-34a-5p;hsa-miR-374a-5p | 11 | CDK6 | Sponge network | 4.214 | 0 | 0.944 | 0 | 0.273 |
86 | RP11-91K9.1 | hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-141-3p;hsa-miR-200a-3p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-26b-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29c-3p;hsa-miR-9-5p | 13 | CDK6 | Sponge network | 3.763 | 0 | 0.944 | 0 | 0.271 |
87 | RP11-64C12.8 | hsa-let-7a-5p;hsa-let-7c-5p;hsa-let-7d-5p;hsa-let-7f-5p;hsa-let-7g-5p;hsa-let-7i-5p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-30b-3p | 11 | CDKN1A | Sponge network | -1.035 | 0.07653 | 0.128 | 0.35863 | 0.267 |
88 | AC006262.5 | hsa-miR-106a-5p;hsa-miR-140-3p;hsa-miR-142-5p;hsa-miR-146a-5p;hsa-miR-148a-5p;hsa-miR-195-5p;hsa-miR-20b-5p;hsa-miR-26a-5p;hsa-miR-30a-3p;hsa-miR-30d-3p;hsa-miR-30e-3p;hsa-miR-374a-5p;hsa-miR-374b-5p;hsa-miR-378a-3p;hsa-miR-497-5p | 15 | CDK6 | Sponge network | 2.376 | 0 | 0.944 | 0 | 0.261 |
89 | RP11-166D19.1 |
hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-590-5p | 10 | SMAD4 | Sponge network | -0.882 | 5.0E-5 | -0.43 | 0 | 0.259 |
90 | TPTEP1 |
hsa-let-7a-3p;hsa-miR-130a-3p;hsa-miR-18a-5p;hsa-miR-19a-3p;hsa-miR-21-3p;hsa-miR-224-5p;hsa-miR-2355-5p;hsa-miR-27a-3p;hsa-miR-454-3p;hsa-miR-576-5p;hsa-miR-590-5p | 11 | SMAD4 | Sponge network | -2.193 | 0 | -0.43 | 0 | 0.257 |
91 | RP11-554I8.2 |
hsa-let-7c-5p;hsa-let-7g-5p;hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-106b-5p;hsa-miR-20b-5p;hsa-miR-28-5p;hsa-miR-30b-3p;hsa-miR-345-5p;hsa-miR-363-3p | 10 | CDKN1A | Sponge network | 0.342 | 0.50007 | 0.128 | 0.35863 | 0.253 |
92 | RP11-356J5.12 | hsa-miR-101-3p;hsa-miR-106a-5p;hsa-miR-146a-5p;hsa-miR-148a-3p;hsa-miR-148a-5p;hsa-miR-200b-3p;hsa-miR-20b-5p;hsa-miR-23b-3p;hsa-miR-26a-5p;hsa-miR-27b-3p;hsa-miR-27b-5p;hsa-miR-29c-3p;hsa-miR-30d-3p | 13 | CDK6 | Sponge network | 0.472 | 0.02484 | 0.944 | 0 | 0.253 |